Cardiology Flashcards

1
Q

What are the three types of acute coronary syndrome?

A

Unstable angina
ST-elevation myocardial infarction (STEMI)
Non-ST-elevation myocardial infarction (NSTEMI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the primary cause of Acute Coronary Syndrome (ACS)?

A

ACS is usually the result of a thrombus from an atherosclerotic plaque blocking a coronary artery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why are antiplatelet medications important in the treatment of ACS?

A

Thrombus formation in a fast-flowing artery is primarily made of platelets, making antiplatelet medications like aspirin, clopidogrel, and ticagrelor essential in treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two main coronary arteries branching from the root of the aorta?

A

Right coronary artery (RCA)
Left coronary artery (LCA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What areas does the right coronary artery (RCA) supply?

A

Right atrium
Right ventricle
Inferior aspect of the left ventricle
Posterior septal area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does the left coronary artery (LCA) become?

A

The LCA branches into the circumflex artery and the left anterior descending (LAD) artery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What areas does the circumflex artery supply?

A

Left atrium
Posterior aspect of the left ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What areas does the left anterior descending (LAD) artery supply?

A

Anterior aspect of the left ventricle
Anterior aspect of the septum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the typical presentation of Acute Coronary Syndrome (ACS)?

A

Central, constricting chest pain
Pain radiating to the jaw or arms
Nausea and vomiting
Sweating and clamminess
A feeling of impending doom
Shortness of breath
Palpitations
Symptoms typically last more than 15 minutes at rest
Silent myocardial infarction: absence of typical chest pain, especially in patients with diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the ECG changes associated with STEMI?

A

ST-segment elevation
New left bundle branch block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the ECG changes associated with NSTEMI?

A

ST segment depression
T wave inversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do pathological Q waves indicate in an ECG?

A

Suggest a deep infarction (transmural)
Typically appear 6 or more hours after onset of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which ECG leads correspond to the left coronary artery?

A

Heart Area: Anterolateral
ECG Leads: I, aVL, V3-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which ECG leads correspond to the left anterior descending artery?

A

Heart Area: Anterior
ECG Leads: V1-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which ECG leads correspond to the circumflex artery?

A

Heart Area: Lateral
ECG Leads: I, aVL, V5-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which ECG leads correspond to the right coronary artery?

A

Heart Area: Inferior
ECG Leads: II, III, aVF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are troponin results used in diagnosing ACS?

A

Troponin is used to diagnose an NSTEMI.
It is not required to diagnose a STEMI (diagnosed based on clinical presentation and ECG).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does a high or rising troponin indicate in suspected ACS?

A

A high or rising troponin in repeat tests indicates an NSTEMI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Name some alternative causes of a raised troponin that are not ACS.

A

Chronic kidney disease
Sepsis
Myocarditis
Aortic dissection
Pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What additional investigations are used in suspected or confirmed ACS?

A

Baseline bloods: FBC, U&E, LFT, lipids, and glucose
Chest x-ray: to investigate pulmonary oedema and other causes of chest pain
Echocardiogram: to assess functional damage to the heart, especially left ventricular function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is STEMI diagnosed in a patient with acute cardiac-sounding chest pain?

A

STEMI is diagnosed when the ECG shows:

ST elevation
New left bundle branch block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is NSTEMI diagnosed in acute coronary syndrome?

A

NSTEMI is diagnosed when there is a raised troponin with either:

A normal ECG
Other ECG changes (ST depression or T wave inversion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How is unstable angina diagnosed?

A

Unstable angina is diagnosed when symptoms suggest ACS, but troponin is normal, with either:

A normal ECG
Other ECG changes (ST depression or T wave inversion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What should be considered if a patient has chest pain but normal ECG and troponin results?

A

The diagnosis could be:

Unstable angina
Another cause, such as musculoskeletal chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the initial management of acute coronary syndrome?

A

C – Call an ambulance
P – Perform an ECG
A – Aspirin 300mg
I – Intravenous morphine for pain if required (with an antiemetic, e.g., metoclopramide)
N – Nitrate (GTN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What should be done when the patient is pain-free but the pain occurred within the past 72 hours?

A

They should be referred to the hospital for same-day assessment, usually seen by the medical team in the Ambulatory Care Unit. Emergency admission is required if there are ECG changes or complications (e.g., heart failure).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How is a STEMI managed if the patient presents within 12 hours of symptom onset?

A

–> Primary PCI within 120 minutes of the time thrombolysis could have been given.
–> Thrombolysis if PCI cannot be performed within 120 minutes. If ST elevation persists 90 minutes after thrombolysis, transfer for PCI.
–> Drug therapy during PCI: unfractionated heparin for radial access or bivalirudin for femoral access.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is percutaneous coronary intervention (PCI) in the management of STEMI?

A

Inserting a catheter into the radial or femoral artery (radial preferred)
Feeding it to the coronary arteries under x-ray guidance
Injecting contrast to identify blockages (angiography)
Treating blockages with balloons (angioplasty) or devices
Usually inserting a stent to keep the artery open

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is thrombolysis and its associated risks in STEMI management?

A

Thrombolysis involves injecting a fibrinolytic agent to break down fibrin in blood clots. It carries a significant risk of bleeding.
Examples: Streptokinase, alteplase, tenecteplase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What mnemonic can be used to remember the medical management of NSTEMI?

A

B: Base decision about angiography and PCI on the GRACE score
A: Aspirin 300mg stat dose
T: Ticagrelor 180mg stat dose (clopidogrel if high bleeding risk, or prasugrel if having angiography)
M: Morphine titrated to control pain
A: Antithrombin therapy with fondaparinux (unless high bleeding risk or immediate angiography)
N: Nitrate (GTN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

When should oxygen be administered in the management of an NSTEMI?

A

Only if oxygen saturation drops below 95% (in someone without COPD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

When should unstable patients with NSTEMI be considered for immediate angiography?

A

Unstable patients (hypotensive) should be considered for immediate angiography, similar to with a STEMI.
Within 72 hours for GRACE score > 3% or new ischemia post-admission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What does the GRACE score assess in NSTEMI?

A

The GRACE score gives a 6-month probability of death after having an NSTEMI.
using factors like age, heart rate, BP, renal function, cardiac arrest on presentation, ECG findings, and troponin levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the GRACE score risk categories?

A

3% or less: Low risk
Above 3%: Medium to high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the drugs used for dual antiplatelet therapy in PCI for NSTEMI/unstable angina?

A

If not on oral anticoagulants: Prasugrel or Ticagrelor
If on oral anticoagulants: Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

When are patients with NSTEMI considered for early angiography with PCI?

A

Patients at medium or high risk (GRACE score > 3%) are considered for early angiography with PCI within 72 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the three key components of ongoing management after the initial management of acute coronary syndrome?

A

Echocardiogram to assess left ventricular function
Cardiac rehabilitation
Secondary prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the mnemonic for secondary prevention medications in ACS?

A

The “6 A’s”:

Aspirin 75mg once daily indefinitely
Another Antiplatelet (e.g., ticagrelor or clopidogrel) for 12 months
Atorvastatin 80mg once daily
ACE inhibitors (e.g., ramipril) titrated as high as tolerated
Atenolol (or another beta-blocker, usually bisoprolol) titrated as high as tolerated
Aldosterone antagonist (e.g., eplerenone) for patients with clinical heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What should be monitored in patients taking ACE inhibitors or aldosterone antagonists?

A

Renal function and potassium levels (risk of hyperkalaemia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What safety update did the MHRA issue in 2016 regarding aldosterone antagonists and ACE inhibitors?

A

Using spironolactone or eplerenone with an ACE inhibitor or angiotensin receptor blocker increases the risk of fatal hyperkalaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the mnemonic to remember the complications of a myocardial infarction?

A

The “DREAD” mnemonic:

D – Death
R – Rupture of the heart septum or papillary muscles
E – “oEdema” (heart failure)
A – Arrhythmia and Aneurysm
D – Dressler’s Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is Dressler’s Syndrome and how does it present?

A

Dressler’s Syndrome (post-myocardial infarction syndrome) occurs 2-3 weeks after an MI due to a localised immune response causing pericarditis.

Presentation:
Pleuritic chest pain
Low-grade fever
Pericardial rub on auscultation
Can cause pericardial effusion and rarely, pericardial tamponade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

How is Dressler’s Syndrome diagnosed?

A

ECG: Global ST elevation, T wave inversion
Echocardiogram: Pericardial effusion
Raised inflammatory markers: CRP and ESR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

How is Dressler’s Syndrome managed?

A

NSAIDs: Aspirin or ibuprofen
Steroids (e.g., prednisolone) for severe cases
Pericardiocentesis for significant pericardial effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is a thoracic aortic aneurysm?

A

A dilation of the thoracic aorta, most commonly affecting the ascending aorta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the normal diameter of the thoracic aorta?

A

Less than 4.5 cm for the ascending aorta and less than 3.5 cm for the descending aorta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is the first sign that a patient may notice with a thoracic aortic aneurysm?

A

The first sign may be when the aneurysm ruptures, leading to life-threatening bleeding into the mediastinum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What is the mortality rate of a ruptured thoracic aortic aneurysm?

A

Extremely high mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What are the three layers of the aorta?

A

Intima, media, and adventitia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What is a false aneurysm (or pseudoaneurysm)?

A

A condition where the inner two layers of the aorta (intima and media) rupture, and the dilation is contained only within the outer (adventitia) layer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What are common causes of false aneurysms?

A

Trauma (e.g., road traffic accidents), surgery to the aorta, or infection in the vessel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What is a true aneurysm?

A

A condition where all three layers of the aorta (intima, media, and adventitia) remain intact but are dilated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

How do thoracic aortic aneurysms typically present?

A

Thoracic aortic aneurysms are often asymptomatic and may be discovered incidentally on investigations such as chest x-rays, echocardiograms, or CT scans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What symptoms can a thoracic aortic aneurysm cause due to occupying space in the mediastinum?

A

Chest or back pain
Cough, shortness of breath, or stridor (from trachea or left bronchus compression)
Hiccups (from phrenic nerve compression)
Dysphagia (difficulty swallowing, from oesophageal compression)
Hoarse voice (from recurrent laryngeal nerve compression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What are the main investigations used to diagnose and assess a thoracic aortic aneurysm?

A

Echocardiogram
CT angiogram
MRI angiogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

How can the risk of progression of a thoracic aortic aneurysm be reduced?

A

By treating modifiable risk factors:
Stop smoking
Healthy diet and exercise
Optimising management of hypertension, diabetes, and hyperlipidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What factors determine management options for thoracic aortic aneurysms?

A

Individual patient factors and the size of the aneurysm. The larger the aneurysm, the higher the risk of rupture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What are the management options for a thoracic aortic aneurysm?

A

Surveillance with regular imaging to monitor size
Thoracic endovascular aortic repair (TEVAR) with a stent graft inserted via the femoral artery
Open surgery (midline sternotomy) to remove the affected section of the aorta and replace it with a synthetic graft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What are the main complications of a thoracic aortic aneurysm?

A

Aortic dissection
Ruptured aneurysm
Aortic regurgitation (if the aortic valve is affected)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What happens when a thoracic aortic aneurysm ruptures?

A

Rupture leads to life-threatening bleeding into the mediastinum, with a high risk of mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

How does the risk of rupture relate to the size of the aneurysm?

A

The risk of rupture increases with the diameter of the aneurysm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What are potential sites for bleeding in a ruptured thoracic aortic aneurysm?

A

Bleeding can occur into:
Oesophagus (causing haematemesis)
Airways or lungs (causing haemoptysis)
Pericardial cavity (causing cardiac tamponade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What are the key clinical features of a ruptured thoracic aortic aneurysm?

A

Severe chest or back pain
Haemodynamic instability (hypotension, tachycardia)
Collapse
Death (often before reaching the hospital)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the emergency treatment for a ruptured thoracic aortic aneurysm?

A

Emergency open surgery is required, where the affected section of the aorta is replaced with a synthetic graft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What is an abdominal aortic aneurysm (AAA)?

A

AAA refers to the dilation of the abdominal aorta with a diameter of more than 3 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

When might a patient first become aware of an AAA?

A

Patients often become aware of an AAA when it ruptures, leading to life-threatening bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What are the risk factors for developing an abdominal aortic aneurysm (AAA)?

A

Men are affected significantly more often and at a younger age than women.
Increased age.
Smoking.
Hypertension.
Family history of AAA.
Existing cardiovascular disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

What is the screening process for abdominal aortic aneurysm (AAA) in England?

A

Men: All men are offered a screening ultrasound at age 65 to detect asymptomatic AAA. Early detection helps prevent further expansion or rupture.

Women: Screening is not routinely offered due to lower risk. NICE guidelines (2020) suggest considering screening in women over 70 with risk factors such as:
- Cardiovascular disease
- COPD
- Family history
- Hypertension
- Hyperlipidaemia
- Smoking

Referral: If the aortic diameter is over 3 cm, referral to a vascular team is needed, with urgent referral if the diameter exceeds 5.5 cm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

How does an abdominal aortic aneurysm (AAA) typically present?

A

Most patients are asymptomatic, with AAA often found on routine screening.
Other possible presentations:
Non-specific abdominal pain
Pulsatile and expansile mass in the abdomen (palpated with both hands)
Incidental finding on abdominal x-ray, ultrasound, or CT scan
Rupture may be the first time patients become aware of it, leading to life-threatening bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What are the key diagnostic investigations for an abdominal aortic aneurysm (AAA)?

A

Ultrasound: The usual initial investigation to establish the diagnosis.
CT angiogram: Provides a more detailed picture of the aneurysm and helps guide elective surgery for repair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

What are the guidelines for aorta width, interpretation, and corresponding actions in AAA?

A

< 3 cm: Normal → No further action
3 - 4.4 cm: Small aneurysm → Rescan every 12 months
4.5 - 5.4 cm: Medium aneurysm → Rescan every 3 months
≥ 5.5 cm: Large aneurysm → Refer within 2 weeks to vascular surgery for probable intervention
Prevalence: Found in only 1 per 1,000 screened patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

How can the risk of progression of an AAA be reduced?

A

–> stop smoking
–> Healthy diet and exercise
–> Optimising the management of hypertension, diabetes, and hyperlipidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What are the NICE (2020) recommendations for elective repair of AAA?

A

Elective repair is recommended for:
Symptomatic aneurysm
Aneurysm growing more than 1 cm per year
Aneurysm diameter above 5.5 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What are the two surgical methods for repairing an AAA?

A

Open repair via a laparotomy
Endovascular aneurysm repair (EVAR) using a stent inserted via the femoral arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

What are the driving restrictions for patients with an AAA according to Gov.uk (April 2021)?

A

Must inform the DVLA if aneurysm is above 6 cm
Stop driving if aneurysm is above 6.5 cm
Stricter rules apply for heavy vehicle drivers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

How does the risk of rupture change with the size of the aneurysm?

A

The risk of rupture increases with the diameter:
5% risk for a 5 cm aneurysm
40% risk for an 8 cm aneurysm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

What is the mortality rate for ruptured AAA?

A

Around 80%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What are the key clinical features of a ruptured AAA?

A

–>Severe abdominal pain, possibly radiating to the back or groin
–> Haemodynamic instability (hypotension and tachycardia)
–>Pulsatile and expansile abdominal mass
Collapse
–> Loss of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

What is the initial management of a ruptured AAA?

A

It is a surgical emergency requiring immediate involvement of vascular surgeons, anaesthetists, and theatre teams.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

What is permissive hypotension in the context of ruptured AAA management?

A

Permissive hypotension refers to the strategy of maintaining lower blood pressure during fluid resuscitation to avoid increasing blood loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

What should be done for haemodynamically unstable patients with a suspected AAA?

A

They should be transferred directly to theatre for surgical repair without delaying for imaging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

When is a CT angiogram used in the management of ruptured AAA?

A

A CT angiogram can be used to diagnose or exclude ruptured AAA in haemodynamically stable patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

What factors might lead to a discussion about palliative care in a ruptured AAA patient?

A

If the patient has co-morbidities that make the prognosis with surgery very poor, a discussion about palliative care may be appropriate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

What conditions should prompt consideration of a ruptured AAA in the differential diagnosis?

A

–> Back pain: In patients over 50 with acute severe back pain, consider an abdominal ultrasound to measure the aortic diameter.
–> Acute pancreatitis: Measure serum amylase/lipase. If normal or mildly raised, perform an abdominal ultrasound to exclude AAA.
–> Renal colic: Even with history of stones and positive urine dip for blood, consider an abdominal ultrasound to rule out AAA.
–> Lower limb ischaemia: Consider abdominal imaging to check for AAA as a cause when evaluating for occlusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

What is an aortic dissection?

A

Aortic dissection occurs when a tear forms in the inner layer of the aorta, allowing blood to flow between the intima and media layers. This creates a false lumen full of blood within the aortic wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

How is aortic dissection classified using the Stanford and DeBakey systems?

A

Stanford system:
Type A: Affects the ascending aorta, before the brachiocephalic artery.
Type B: Affects the descending aorta, after the left subclavian artery.
DeBakey system:
Type I: Begins in the ascending aorta and involves at least the aortic arch or the whole aorta.
Type II: Isolated to the ascending aorta.
Type IIIa: Begins in the descending aorta and involves only the section above the diaphragm.
Type IIIb: Begins in the descending aorta and involves the aorta below the diaphragm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

What are the risk factors for aortic dissection?

A

Shared with peripheral arterial disease:
Age, male sex, smoking, hypertension, poor diet, reduced physical activity, and raised cholesterol.

Hypertension: Major risk factor, can be triggered by events like heavy weightlifting or cocaine use.

Aortic conditions/procedures:
Bicuspid aortic valve
Coarctation of the aorta
Aortic valve replacement
Coronary artery bypass graft (CABG)

Connective tissue disorders:
Ehlers-Danlos Syndrome
Marfan’s Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What are the key diagnostic features of aortic dissection?

A

–> Classic symptom: Sudden onset, severe, “ripping” or “tearing” chest pain.
Pain location:
- Anterior chest pain: Ascending aorta affected.
- Back pain: Descending aorta affected.
Pain migration: Pain may change location over time.

Other features:
Hypertension: Present in many cases.
Blood pressure difference: A difference >20mmHg between arms is significant.
Radial pulse deficit: One arm’s radial pulse is decreased/absent compared to the apex beat.
Diastolic murmur: Due to aortic regurgitation.
Neurological signs: Focal deficits, e.g., limb weakness or paraesthesia.
Chest/abdominal pain: Pain in both areas may be present.
Collapse/syncope: Especially as the dissection progresses.
Hypotension: As a late feature or sign of progression.

Signs of organ malperfusion:
Stroke: Carotid artery involvement.
Myocardial infarction: Coronary ostia obstruction.
Paraplegia: Spinal artery compromise.
Mesenteric ischemia: Abdominal pain.
Renal failure: Renal artery occlusion.
Cardiovascular collapse: Sudden death if the ascending aorta ruptures into the pericardium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What are the key investigations used in diagnosing aortic dissection?

A

Chest x-ray:
Widened mediastinum may suggest aortic dissection.
CT angiography of the chest, abdomen, and pelvis:
Investigation of choice for stable patients.
Helps with surgical planning.
A false lumen is a key diagnostic finding.
Transoesophageal echocardiography (TOE):
Preferred for unstable patients who cannot be safely moved for a CT scan.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

What are the management strategies for Type A and Type B aortic dissection?

A

Type A (affects the ascending aorta):
Surgical management is required.
Blood pressure control to a target systolic of 100-120 mmHg using IV medications while awaiting surgery.

Type B (affects the descending aorta):
Conservative management:
Bed rest.
Reduce blood pressure with IV labetalol to prevent progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What are some key complications of aortic dissection to remember?

A

Myocardial infarction
Stroke
Paraplegia (motor or sensory impairment in the legs)
Cardiac tamponade
Aortic valve regurgitation
Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What is Acute Limb Ischaemia (ALI)?

A

A sudden decrease in arterial blood flow to a limb, threatening its viability, with an incidence of ~1.5 cases per 10,000 per year, primarily affecting the lower limbs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

What are the main causes of acute limb ischaemia?

A

Thrombosis (80-85%)
Embolism (10-15%)
Trauma (5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

What are common causes of thrombosis in ALI?

A

Plaque rupture in atherosclerotic segments
Hypovolaemia
Thrombophilia
Hypotension
Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

What are common sources of embolism in ALI?

A

Left atrium (atrial fibrillation)
Mural thrombus (myocardial infarction)
Prostheses (heart valves or bypass grafts)
Aneurysms (e.g., popliteal, abdominal aortic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

What are the risk factors for ALI?

A

Smoking
Diabetes mellitus
Obesity
Hypertension
Hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

What are the classical clinical features of ALI?

A

The six P’s:

Pain
Pallor
Pulselessness
Perishingly cold (poikilothermia)
Paraesthesia
Paralysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

How can you distinguish between embolic and thrombotic ALI?

A

Embolic ALI: Sudden onset, severe symptoms, normal contralateral pulses
Thrombotic ALI: Gradual onset, less severe symptoms, absent contralateral pulses, history of PAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

What is the Rutherford classification for ALI?

A

Stage I: Limb viable
Stage IIa: Limb marginally threatened
Stage IIb: Limb immediately threatened
Stage III: Limb irreversibly damaged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

What are differential diagnoses for ALI?

A

Critical limb ischaemia (CLI)
Acute deep vein thrombosis
Peripheral neuropathy
Compartment syndrome
Thromboangiitis obliterans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

What are the key investigations for ALI?

A

Bedside: Duplex ultrasound/Doppler scan, ECG
Laboratory: FBC, U&E, LFTs, coagulation, serum lactate
Imaging: CT/MR angiography, echocardiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

What is the initial management of ALI?

A

Emergency vascular specialist assessment
Systemic anticoagulation with heparin
Analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

What are the surgical management options for ALI?

A

Thrombotic causes: Thrombolysis, thrombectomy, bypass surgery
Embolic causes: Embolectomy, thrombolysis, bypass surgery
Non-viable limbs: Amputation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

What long-term management strategies should be implemented for ALI patients?

A

Smoking cessation
Lifestyle modifications (diet and exercise)
Statin therapy
Management of diabetes and hypertension
Antiplatelet therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

What are the complications associated with ALI?

A

High mortality rate (15-20%)
Reperfusion injury
Compartment syndrome
Peripheral nerve injury
Psychosocial impacts of amputation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

What are the common clinical features of symptomatic aortic stenosis?

A

Chest pain
Dyspnoea
Syncope / presyncope (e.g., exertional dizziness)
Murmur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

What type of murmur is classically associated with aortic stenosis?

A

An ejection systolic murmur (ESM) that radiates to the carotids and is decreased following the Valsalva maneuver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

What are the features of severe aortic stenosis?

A

Narrow pulse pressure
Slow rising pulse
Delayed ejection systolic murmur (ESM)
Soft or absent S2
S4 gallop
Thrill
Prolonged duration of murmur
Left ventricular hypertrophy or failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

What are the common causes of aortic stenosis?

A

Degenerative calcification (most common in patients > 65 years)
Bicuspid aortic valve (most common in patients < 65 years)
William’s syndrome (supravalvular aortic stenosis)
Post-rheumatic disease
Subvalvular aortic stenosis (e.g., hypertrophic obstructive cardiomyopathy - HOCM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

What is the management approach for asymptomatic aortic stenosis?

A

Generally observe the patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

What should be done for symptomatic aortic stenosis?

A

Valve replacement is indicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

When should surgery be considered for asymptomatic patients with aortic stenosis?

A

If there is a valvular gradient > 40 mmHg and features such as left ventricular systolic dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

What are the options for aortic valve replacement (AVR)?

A

–> Surgical AVR: Treatment of choice for young, low/medium operative risk patients; often combined with angiogram due to potential cardiovascular disease.
–> Transcatheter AVR (TAVR): Used for patients with high operative risk.
–> Balloon valvuloplasty: May be used in children without aortic valve calcification and limited to adults with critical aortic stenosis who are not fit for valve replacement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

What is aortic regurgitation (AR)?

A

AR is the leaking of the aortic valve of the heart that causes blood to flow in the reverse direction during ventricular diastole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

What are the two main categories of causes for aortic regurgitation?

A

Disease of the aortic valve
Distortion or dilation of the aortic root and ascending aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What are the causes of aortic regurgitation due to valve disease?

A

Chronic: rheumatic fever: the most common cause in the developing world
calcific valve disease
connective tissue diseases e.g. rheumatoid arthritis/SLE
bicuspid aortic valve (affects both the valves and the aortic root)
Acute: Infective endocarditis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

What are the causes of aortic regurgitation due to aortic root disease?

A

Chronic: bicuspid aortic valve (affects both the valves and the aortic root)
spondylarthropathies (e.g. ankylosing spondylitis)
hypertension
syphilis
Marfan’s, Ehler-Danlos syndrome
Acute: Aortic dissection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

What are the clinical features of aortic regurgitation (AR)?

A

Early diastolic murmur (increased with handgrip)
Collapsing pulse
Wide pulse pressure
Quincke’s sign (nailbed pulsation)
De Musset’s sign (head bobbing)
Mid-diastolic Austin-Flint murmur in severe AR (due to partial closure of mitral valve)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

How is suspected aortic regurgitation investigated?

A

Suspected AR should be investigated with echocardiography.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

What is the management for aortic regurgitation?

A

Medical management of any associated heart failure
Surgical indications include:
Symptomatic patients with severe AR
Asymptomatic patients with severe AR and LV systolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

What are arrhythmias?

A

Arrhythmias are abnormal heart rhythms caused by interruptions in the normal electrical signals that coordinate heart muscle contractions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

What are the four possible rhythms in a pulseless patient?

A

Shockable rhythms:
Ventricular tachycardia
Ventricular fibrillation
Non-shockable rhythms:
Pulseless electrical activity (PEA)
Asystole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

What distinguishes shockable rhythms from non-shockable rhythms?

A

Shockable rhythms (VT, VF) may respond to defibrillation, while non-shockable rhythms (PEA, asystole) will not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

What is narrow complex tachycardia?

A

Narrow complex tachycardia is a fast heart rate characterized by a QRS complex duration of less than 0.12 seconds, fitting within 3 small squares on a standard ECG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

What are the four main differentials for narrow complex tachycardia and how are they normally treated?

A

Sinus tachycardia (treatment focuses on the underlying cause)
Supraventricular tachycardia (treated with vagal manoeuvres and adenosine)
Atrial fibrillation (treated with rate control or rhythm control)
Atrial flutter (treated with rate control or rhythm control, similar to atrial fibrillation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

How is sinus tachycardia distinguished from other forms of tachycardia?

A

Sinus tachycardia maintains a normal P wave, QRS complex, and T wave pattern and usually occurs in response to an underlying cause (e.g., sepsis, pain).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

What is a key feature of supraventricular tachycardia (SVT) on ECG?

A

SVT shows a regular rhythm with QRS complexes followed by T waves, but P waves are often buried in the T waves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

How can you differentiate supraventricular tachycardia (SVT) from sinus tachycardia?

A

SVT has an abrupt onset and a very regular rhythm without variability. In contrast, sinus tachycardia presents with a gradual onset and greater variability in the heart rate. Sinus tachycardia often has identifiable causes (e.g., pain, fever), whereas SVT may occur at rest without an obvious reason.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

How can atrial fibrillation be identified on an ECG?

A

Atrial fibrillation is characterized by absent P waves and an irregularly irregular ventricular rhythm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

What distinguishes atrial flutter on an ECG?

A

Atrial flutter typically shows a saw-tooth pattern with an atrial rate of around 300 beats per minute, often resulting in a ventricular rate of 150 beats per minute.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

What is the typical atrial rate in atrial flutter, and how does it affect the ventricular rate?

A

The atrial rate in atrial flutter is usually around 300 beats per minute, creating a saw-tooth pattern on the ECG. Due to conduction from the atria, a QRS complex occurs at regular intervals, often resulting in two atrial contractions for every one ventricular contraction, leading to a ventricular rate of approximately 150 beats per minute. 2: conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

What is the treatment for patients with life-threatening features of narrow complex tachycardia?

A

Patients with life-threatening features should be treated with synchronized DC cardioversion under sedation or general anesthesia, with intravenous amiodarone if initial shocks are unsuccessful.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

What defines broad complex tachycardia, and how is it classified according to resuscitation guidelines?

A

Broad complex tachycardia is defined as a fast heart rate with a QRS complex duration of more than 0.12 seconds (or 3 small squares) on an ECG. It is classified into:

Ventricular tachycardia or unclear cause (treated with IV amiodarone).
Polymorphic ventricular tachycardia (e.g., torsades de pointes, treated with IV magnesium).
Atrial fibrillation with bundle branch block (treated as AF).
Supraventricular tachycardia with bundle branch block (treated as SVT).

Patients with life-threatening features may require synchronized DC cardioversion and IV amiodarone if shocks are unsuccessful.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

What is atrial flutter?

A

Atrial flutter is caused by a re-entrant rhythm in the atria, where electrical signals circulate in a self-perpetuating loop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

What is the typical atrial rate in atrial flutter?

A

The atrial rate is usually around 300 beats per minute.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

How does atrial flutter appear on an ECG?

A

Atrial flutter gives a sawtooth appearance on the ECG, with repeated P waves at around 300 per minute and narrow complex tachycardia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

What is the conduction pattern in atrial flutter?

A

The signal may not enter the ventricles on every lap, often resulting in 2:1 conduction, giving a ventricular rate of about 150 beats per minute.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

What are the potential conduction ratios in atrial flutter?

A

The conduction ratios may also be 3:1, 4:1, or variable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

What is the treatment for atrial flutter?

A

Treatment includes anticoagulation based on the CHA2DS2-VASc score and radiofrequency ablation of the re-entrant rhythm as a potential permanent solution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

What is the QT interval?

A

The QT interval is the duration from the start of the QRS complex to the end of the T wave.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

What is the corrected QT interval (QTc)?

A

The QTc estimates the QT interval if the heart rate were 60 beats per minute.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

What is considered a prolonged QT interval in men?

A

More than 440 milliseconds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

What is considered a prolonged QT interval in women?

A

More than 460 milliseconds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

What does a prolonged QT interval represent?

A

Prolonged repolarisation of the heart muscle cells (myocytes) after contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

What are afterdepolarisations and what is this called?

A

Waiting a long time for repolarisation can result in spontaneous depolarisation in some muscle cells. These abnormal spontaneous depolarisations before repolarisation are known as afterdepolarisations. These afterdepolarisations spread throughout the ventricles, causing a contraction before proper repolarisation. When this leads to recurrent contractions without normal repolarisation, it is called torsades de pointes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

What is torsades de pointes?

A

A type of polymorphic ventricular tachycardia characterized by a twisting appearance of the QRS complex on ECG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

What causes torsades de pointes?

A

It can be caused by prolonged QT intervals, leading to recurrent contractions without normal repolarisation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

What are common causes of prolonged QT intervals?

A

Long QT syndrome, certain medications (antipsychotics, citalopram, flecainide, sotalol, amiodarone and macrolide antibiotics) , and electrolyte imbalances (e.g., hypokalaemia/hypomagnesemia/ hypocalcaemia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

What is the management for a prolonged QT interval?

A

Stop medications prolonging QT, correct electrolyte disturbances, and consider beta blockers (not sotalol) or devices like pacemakers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

What is the acute management for torsades de pointes?

A

Correct underlying causes, administer magnesium infusion, and defibrillate if ventricular tachycardia occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

What are ventricular ectopics?

A

Premature ventricular beats caused by random electrical discharges outside the atria, often presenting as extra or missed beats.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

In which patients are ventricular ectopics more common?

A

They are more common in patients with pre-existing heart conditions, such as ischaemic heart disease or heart failure.

common in all ages and in healthy people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

How do ventricular ectopics appear on an ECG?

A

As isolated, random, abnormal, broad QRS complexes on an otherwise normal ECG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

What is bigeminy in the context of ventricular ectopics?

A

A rhythm where every other beat is a ventricular ectopic, alternating with a normal beat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

What is the management approach for ventricular ectopics in otherwise healthy individuals?

A

Reassurance and no treatment for infrequent ectopics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

When should specialist advice be sought for ventricular ectopics?

A

In patients with underlying heart disease, frequent or concerning symptoms, or a family history of heart disease or sudden death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

What medication is sometimes used to manage symptoms of ventricular ectopics?

A

Beta blockers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

What are the two types of second-degree heart block?

A

Mobitz type 1 (Wenckebach phenomenon) and Mobitz type 2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

Describe Mobitz type 1 (Wenckebach phenomenon).

A

The PR interval progressively lengthens until a P wave is not followed by a QRS complex, after which the cycle resets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

How does Mobitz type 2 differ from Mobitz type 1?

A

Mobitz type 2 has intermittent failure of conduction with absent QRS complexes following P waves, while the PR interval remains normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

What is a common feature of a 2:1 block?

A

There are two P waves for each QRS complex, with every other P wave not stimulating a QRS complex., difficult to tell whether this is mobitz type 1 or 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

What is teh common feature of mobitz type 2, 3:1 block

A

There is usually a set ratio of P waves to QRS complexes, for example, three P waves for each QRS complex (3:1 block).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

What is third-degree heart block?

A

Also known as complete heart block, there is no observable relationship between P waves and QRS complexes, with a significant risk of asystole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

What characterises first-degree heart block?

A

It is marked by delayed conduction through the atrioventricular node, with every P wave followed by a QRS complex. The PR interval is greater than 0.2 seconds (5 small squares or 1 big square) on ECG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

What is the key feature of second-degree heart block?

A

In second-degree heart block, some atrial impulses do not reach the ventricles, resulting in P waves that are not followed by QRS complexes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q

What is bradycardia?

A

Bradycardia refers to a slow heart rate, typically less than 60 beats per minute. It can be normal in fit patients without symptoms. Common causes include medications (e.g., beta blockers), heart block, and sick sinus syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

What is sick sinus syndrome?

A

Sick sinus syndrome is a condition that causes dysfunction in the sinoatrial node, often due to idiopathic degenerative fibrosis. It can result in sinus bradycardia, sinus arrhythmias, and prolonged pauses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

What is asystole?

A

Asystole refers to the absence of electrical activity in the heart, resulting in cardiac arrest. There is a risk of asystole in conditions like Mobitz type 2, third-degree heart block, previous asystole, and ventricular pauses longer than 3 seconds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

What are the management options for unstable patients at risk of asystole?

A

Management includes
–> intravenous atropine (first line),
–> inotropes (e.g., isoprenaline or adrenaline)
–> temporary cardiac pacing, and when available
–> permanent implantable pacemaker.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

What are the methods for temporary cardiac pacing?

A

Temporary cardiac pacing can be done via transcutaneous pacing (using pads on the chest) or transvenous pacing (using a catheter to stimulate the heart directly).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
171
Q

How does atropine work and what are its side effects?

A

Atropine is an antimuscarinic medication that inhibits the parasympathetic nervous system, leading to side effects such as pupil dilation, dry mouth, urinary retention, and constipation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
172
Q

What is atrial fibrillation (AF)?

A

AF is a condition where the electrical activity in the atria becomes disorganised, leading to fibrillation (random muscle twitching) of the atria and an irregularly irregular pulse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
173
Q

What are the effects of atrial fibrillation on the heart?

A

Irregularly irregular ventricular contractions
Tachycardia (fast heart rate)
Heart failure due to impaired ventricular filling
Increased risk of stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
174
Q

What is the normal role of the sinoatrial node in heart contraction?

A

The sinoatrial node normally produces organised electrical activity that coordinates atrial contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
175
Q

How does atrial fibrillation lead to irregular ventricular contractions?

A

Chaotic atrial electrical activity overrides the sinoatrial node’s regular impulses, passing to the ventricles and causing irregularly irregular ventricular contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
176
Q

Why is there a risk of stroke in atrial fibrillation?

A

Uncoordinated atrial activity may cause blood stagnation and thrombus formation in the atria. A thrombus in the left atrium can travel to the brain, causing an ischaemic stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
177
Q

What mnemonic helps remember the common causes of atrial fibrillation?

A

The mnemonic “SMITH” helps remember common causes of atrial fibrillation:
Sepsis
Mitral valve pathology
Ischaemic heart disease
Thyrotoxicosis
Hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
178
Q

What lifestyle factors are associated with atrial fibrillation?

A

Alcohol and caffeine are lifestyle causes of atrial fibrillation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
179
Q

What is the typical presentation of atrial fibrillation?

A

Patients may be asymptomatic or present with palpitations, shortness of breath, dizziness, syncope, or symptoms related to associated conditions like stroke, sepsis, or thyrotoxicosis. The key examination finding is an irregularly irregular pulse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
180
Q

What are the differential diagnoses for an irregularly irregular pulse?

A

Atrial fibrillation and ventricular ectopics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
181
Q

How can you distinguish ventricular ectopics from atrial fibrillation?

A

Ventricular ectopics tend to disappear when the heart rate increases, such as during exercise, unlike atrial fibrillation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
182
Q

What are the ECG findings in atrial fibrillation?

A

ECG findings in atrial fibrillation include absent P waves, narrow QRS complex tachycardia, and an irregularly irregular ventricular rhythm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
183
Q

When might an echocardiogram be required in atrial fibrillation patients?

A

An echocardiogram may be required when investigating valvular heart disease, heart failure, or before planning cardioversion.

184
Q

What is paroxysmal atrial fibrillation?

A

Paroxysmal atrial fibrillation refers to episodes of AF that reoccur and spontaneously resolve back to sinus rhythm, lasting between 30 seconds and 48 hours.

185
Q

What further investigations can be done for suspected paroxysmal atrial fibrillation with a normal ECG?

A

Further investigations include a 24-hour ambulatory ECG (Holter monitor) or a cardiac event recorder lasting 1-2 weeks.

186
Q

What is valvular atrial fibrillation?

A

Valvular atrial fibrillation occurs with significant mitral stenosis or a mechanical heart valve, where the valvular pathology has likely caused the AF.

187
Q

What is the management recommendation for valvular atrial fibrillation according to NICE 2021 guidelines?

A

NICE 2021 recommends referral to a cardiologist for further assessment and management of patients with valvular atrial fibrillation.

188
Q

What are the two principles in the management of atrial fibrillation according to the NICE guidelines (2021)?

A
  1. Rate or rhythm control
  2. Anticoagulation to prevent strokes
189
Q

What is the first-line rate control treatment for atrial fibrillation?

A

A beta blocker, such as atenolol or bisoprolol, is the first-line treatment for rate control.

190
Q

What are the options for rate control in AF management?

A

Beta blockers (first-line, e.g., atenolol, bisoprolol)
Calcium-channel blockers (e.g., diltiazem, verapamil)
Digoxin (in sedentary patients)

191
Q

When is rhythm control preferred in AF management?

A

Rhythm control is preferred when there is:

A reversible cause
New onset AF (<48 hours)
AF causing heart failure
Symptoms despite rate control

192
Q

What are the rhythm control options for managing atrial fibrillation?

A

Cardioversion: Immediate or delayed
Pharmacological agents: Flecainide, amiodarone
Electrical cardioversion

193
Q

What is the purpose of anticoagulation before delayed cardioversion in AF?

A

To prevent stroke by reducing the risk of dislodging a thrombus formed in the atria.

194
Q

What is the difference between immediate and delayed cardioversion in atrial fibrillation?

A

Immediate Cardioversion: Used if AF is present for <48 hours or causes life-threatening hemodynamic instability.
Delayed Cardioversion: Used if AF has been present for >48 hours and the patient is stable; requires anticoagulation for at least 3 weeks prior to reduce stroke risk.

195
Q

What are the options for pharmacological and electrical cardioversion in atrial fibrillation?

A

Pharmacological Cardioversion Options:

Flecainide
Amiodarone (especially in structural heart disease)
Electrical Cardioversion: Uses a defibrillator to deliver controlled shocks, usually done under sedation or general anesthesia.

196
Q

What are the long-term rhythm control options after successful cardioversion in atrial fibrillation?

A

Beta blockers (first-line)
Dronedarone (second-line for maintaining normal rhythm)
Amiodarone (useful in patients with heart failure or left ventricular dysfunction)

197
Q

What is the “pill-in-the-pocket” approach for managing paroxysmal atrial fibrillation?

A

The “pill-in-the-pocket” (Flecainide) approach allows patients to take medication to terminate atrial fibrillation symptoms as they arise. This method is suitable for patients with infrequent episodes and no structural heart disease, who can recognize AF signs and when to take treatment. Flecainide is commonly used for this approach, but it carries the risk of converting AF to atrial flutter with rapid ventricular rates.

198
Q

How should anticoagulation be managed in patients with paroxysmal atrial fibrillation?

A

Patients with paroxysmal atrial fibrillation should be anticoagulated based on their CHA₂DS₂-VASc score, similar to those with permanent atrial fibrillation.

199
Q

What are the two options for ablation when drug treatment for atrial fibrillation is inadequate?

A

Left atrial ablation - A catheter-based procedure to destroy abnormal electrical pathways in the left atrium using radiofrequency energy.
Atrioventricular node ablation - Destroys the connection between the atria and ventricles, requiring a permanent pacemaker to manage ventricular contraction.

200
Q

How is left atrial ablation performed?

A

Left atrial ablation is performed under general anaesthesia or sedation in a catheter laboratory. A catheter is inserted via a femoral vein and guided to the heart, where it punctures the septum into the left atrium. The operator identifies abnormal electrical pathways and applies radiofrequency ablation to create scar tissue that disrupts the arrhythmia.

201
Q

What is required after atrioventricular node ablation?

A

After atrioventricular node ablation, a permanent pacemaker is needed to control ventricular contractions since the irregular electrical activity from the atria cannot reach the ventricles. Anticoagulation remains necessary to prevent strokes.

202
Q

Why is anticoagulation important in patients with atrial fibrillation?

A

Anticoagulation is essential because uncontrolled atrial activity can lead to blood stagnation in the left atrium, resulting in thrombus formation. This thrombus can mobilize and cause an ischaemic stroke by traveling to the brain. Anticoagulation reduces the risk of stroke in these patients from about 5% annually to 1-2% by interfering with the clotting cascade, lowering stroke risk by approximately two-thirds.

203
Q

What are the risks associated with anticoagulation treatment?

A

Anticoagulation treatment carries a risk of serious bleeding ranging from 2.5% to 8% per year, depending on individual factors.

204
Q

What do the NICE guidelines (2021) recommend for anticoagulation in atrial fibrillation?

A

The NICE guidelines recommend using direct-acting oral anticoagulants (DOACs) as the first-line treatment. Warfarin is recommended as a second-line option if DOACs are contraindicated.

205
Q

What are the main characteristics of direct-acting oral anticoagulants (DOACs)?

A

DOACs do not require INR monitoring, making them suitable for most patients, including those with cancer. They have a half-life of 6-14 hours.

Common DOACs include apixaban, edoxaban, rivaroxaban (all direct factor Xa inhibitors), and dabigatran (a direct thrombin inhibitor). Apixaban and dabigatran are taken twice daily, while edoxaban and rivaroxaban are taken once daily.

206
Q

What advantages do DOACs have over warfarin?

A

DOACs require no monitoring, have no time in therapeutic range issues (with good adherence), and fewer major interactions. They are equally or slightly more effective than warfarin in preventing strokes in atrial fibrillation and have an equal or slightly lower risk of bleeding.

207
Q

What are common indications for prescribing DOACs?

A

DOACs are commonly indicated for stroke prevention in atrial fibrillation, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prophylaxis of venous thromboembolism after hip or knee replacements.

208
Q

What is the mechanism of action of warfarin?

A

Warfarin is a vitamin K antagonist that blocks vitamin K, essential for the functioning of several clotting factors. This action prolongs the prothrombin time, increasing the time it takes for blood to clot.

209
Q

How is the effectiveness of warfarin monitored?

A

The effectiveness of warfarin is monitored using the INR (international normalized ratio), which compares the patient’s prothrombin time to that of a healthy adult. The target INR for atrial fibrillation (AF) is between 2 and 3.

210
Q

What factors can affect INR levels in patients taking warfarin?

A

INR levels can be affected by medications influencing the cytochrome P450 system, dietary changes, particularly those involving vitamin K-rich foods, and the consumption of substances like cranberry juice and alcohol.

211
Q

What is the importance of monitoring time in therapeutic range (TTR) for warfarin?

A

TTR indicates the percentage of time the INR is in the target range. Low INR increases stroke risk; high INR increases bleeding risk. Frequent monitoring is necessary for dose adjustments.

212
Q

How does warfarin metabolism affect INR levels?

A

Warfarin metabolism involves the cytochrome P450 system, meaning that medications affecting this system (e.g., certain antibiotics) can alter INR levels, requiring close monitoring and dose adjustments.

213
Q

What dietary factors influence INR levels in patients on warfarin?

A

Foods high in vitamin K (like leafy greens) and substances that affect the P450 system (like cranberry juice and alcohol) can influence INR levels, necessitating careful dietary management.

214
Q

How can the effects of warfarin be reversed?

A

The effects of warfarin can be reversed using vitamin K in cases of significantly high INR or major bleeding.

215
Q

What is the half-life of warfarin?

A

Warfarin has a half-life of 1-3 days, affecting the duration of its anticoagulant effect.

216
Q

What does CHA2DS2-VASc stand for?

A

CHA2DS2-VASc is an acronym for risk factors: Congestive heart failure, Hypertension, Age > 75 (2 points), Diabetes, Stroke or TIA (2 points), Vascular disease, Age 65-74, and Sex (female).

217
Q

How is the CHA2DS2-VASc score used to assess anticoagulation need?

A

A score of 0 indicates no anticoagulation; a score of 1 suggests considering anticoagulation in men (women automatically score 1); a score of 2 or more warrants offering anticoagulation.

218
Q

What is the current stance on using aspirin for stroke prevention in atrial fibrillation?

A

Aspirin alone is not recommended for stroke prevention in atrial fibrillation; it was an option in the past but is now considered ineffective compared to anticoagulants.

219
Q

What does the ORBIT acronym stand for in assessing bleeding risk?

A

O - Older age (≥75),
R - Renal impairment (GFR < 60),
B - Bleeding history (GI or intracranial),
I - Iron deficiency (low hemoglobin/hematocrit),
T - Taking antiplatelet medication.

220
Q

What is left atrial appendage occlusion, and when is it indicated?

A

Left atrial appendage occlusion is a procedure for patients with contraindications to anticoagulation and a high stroke risk, preventing blood from entering the left atrial appendage to reduce thrombus formation.

221
Q

What is supraventricular tachycardia (SVT)?

A

SVT refers to a fast heart rate caused by abnormal electrical signals from above the ventricles.

222
Q

What mechanism causes SVT?

A

SVT is caused by the electrical signal re-entering the atria from the ventricles, creating a self-perpetuating electrical loop.

223
Q

How is SVT characterized in terms of QRS complex duration?

A

SVT is characterized as “narrow complex” tachycardia, with a QRS complex duration of less than 0.12 seconds.

224
Q

What is paroxysmal SVT?

A

Paroxysmal SVT describes recurrent episodes of SVT that remit and return over time in the same patient.

225
Q

What are the three main types of SVT based on the source of the abnormal electrical signal?

A

Atrioventricular nodal re-entrant tachycardia
Atrioventricular re-entrant tachycardia
Atrial tachycardia

226
Q

What is atrioventricular nodal re-entrant tachycardia?

A

It is a type of SVT where the re-entry point is back through the atrioventricular node, and it is the most common type of SVT.

227
Q

Describe atrioventricular re-entrant tachycardia

A

This type involves an accessory pathway that allows electrical signals to re-enter the atria from the ventricles, often associated with Wolff-Parkinson-White syndrome.

228
Q

What characterises atrial tachycardia?

A

Atrial tachycardia occurs when the electrical signal originates in the atria, not from re-entering signals from the ventricles, indicating abnormally generated electrical activity.

229
Q

What are the three types of supraventricular tachycardia (SVT)?

A

–> Atrioventricular nodal re-entrant tachycardia: Re-entry through the AV node; most common type.
–> Atrioventricular re-entrant tachycardia: Involves an accessory pathway allowing signals to re-enter from the ventricles; associated with Wolff-Parkinson-White syndrome.
–> Atrial tachycardia: Abnormal electrical activity originates in the atria, not from re-entry from the ventricles.

230
Q

What is Wolff-Parkinson-White Syndrome?

A

Wolff-Parkinson-White (WPW) syndrome is caused by an extra electrical pathway (Bundle of Kent) connecting the atria and ventricles, bypassing the AV node. It may cause episodes of SVT.

231
Q

What are the ECG changes and treatment for Wolff-Parkinson-White Syndrome?

A

ECG Changes:

Short PR interval (<0.12 seconds)
Wide QRS complex (>0.12 seconds)
Delta wave (slurred upstroke in QRS)
Treatment: The definitive treatment is radiofrequency ablation of the accessory pathway.

232
Q

What is the stepwise approach for managing supraventricular tachycardia (SVT) in patients without life-threatening features?

A

Vagal manoeuvres
Adenosine
Verapamil or a beta blocker
Synchronized DC cardioversion
Note: Continuous ECG monitoring is essential during management.

233
Q

How should patients with life-threatening features or Wolff-Parkinson-White syndrome be managed during SVT?

A

Life-Threatening Features: Use synchronized DC cardioversion under sedation or general anesthesia. If initial shocks fail, add intravenous amiodarone.
Wolff-Parkinson-White Syndrome: Avoid adenosine, verapamil, or beta blockers. Use procainamide or electrical cardioversion if unstable. as these block the atrioventricular node, promoting conduction of the atrial rhythm through the accessory pathway into the ventricles, causing potentially life-threatening ventricular rhythms

234
Q

What are the types and mechanisms of vagal maneuvers used to terminate supraventricular tachycardia (SVT)?

A

Valsalva Maneuver: Increases intrathoracic pressure by having the patient blow hard against resistance (e.g., into a 10ml syringe for 10-15 seconds).
Carotid Sinus Massage: Stimulates baroreceptors by massaging one side of the neck (not both) but is contraindicated in carotid artery stenosis.
Diving Reflex: Involves briefly submerging the patient’s face in cold water to activate the reflex.

235
Q

How does adenosine work in the management of supraventricular tachycardia (SVT), and what are its contraindications?

A

Adenosine slows cardiac conduction through the AV node, effectively “resetting” it to sinus rhythm. Its half-life is under 10 seconds, requiring rapid IV bolus administration. Common side effects include brief asystole or bradycardia.
Contraindications:

Asthma
COPD
Heart failure
Heart block
Severe hypotension
Potential atrial arrhythmia with pre-excitation

Dosing: Start with 6 mg, then 12 mg, and finally 18 mg as needed.

236
Q

What is synchronized DC cardioversion, and when is it used?

A

Synchronized DC cardioversion delivers an electric shock to the heart to restore normal sinus rhythm, timed with the R wave on the ECG. It is used in patients with a pulse to avoid shocks during the T wave, which can cause ventricular fibrillation. In cases of pulseless ventricular tachycardia or ventricular fibrillation, synchronization is not necessary

237
Q

What are the management options for paroxysmal supraventricular tachycardia (SVT)?

A

Management options for recurrent SVT include long-term medication (e.g., beta blockers, calcium channel blockers, or amiodarone) and radiofrequency ablation to prevent further episodes.

238
Q

What is radiofrequency ablation and what arrhythmias can it resolve?

A

Radiofrequency ablation involves inserting a catheter to identify and burn abnormal electrical pathways in the heart, creating scar tissue that prevents conduction. It can permanently resolve arrhythmias such as atrial fibrillation, atrial flutter, supraventricular tachycardias, and Wolff-Parkinson-White syndrome.

239
Q

What are the key risk factors for developing DVT?

A

Demographic: Male, over 60
Immobilisation: Hospitalisation (10x risk), long-haul flights (2x risk)
Inflammation: Vasculitis, sepsis
Malignancy: 20% of DVT/PE patients have cancer
Medication: Chemotherapy, HRT, OCP
Obesity: BMI >30 (2-3x risk)
Pregnancy: 5x risk due to prothrombotic state
Previous VTE
Recent surgery/trauma
Smoking, varicose veins

240
Q

What is Virchow’s triad, and how does it contribute to DVT formation?

A

Virchow’s triad includes three changes contributing to venous thrombosis:

Hypercoagulability: Hereditary (e.g., factor V Leiden) and acquired (e.g., malignancy, pregnancy, OCP) causes.
Stasis of blood: Immobilisation (e.g., casts, long-haul flights).
Endothelial changes: Dysfunction (e.g., hypertension, smoking) or damage (e.g., trauma, central lines).

241
Q

What are the typical clinical features of deep vein thrombosis (DVT)?

A

–> Unilateral leg pain (lower leg, cramping, or throbbing)
–> Swelling, mostly in the calf (can extend to the entire leg in extensive cases)
–> Pitting oedema
–> Skin changes: erythema, cyanosis, or pallor
–> Distended superficial veins (in ~17% of cases)
–> Increased leg temperature and tenderness over deep veins
–> Significant calf size difference (>3cm)

DVT often coexists with pulmonary embolism in 40-50% of patients.

242
Q

What are the steps in assessing and managing suspected DVT using the two-level DVT Wells score?

A

Two-level DVT Wells Score:

Active cancer (1 point)
Paralysis or immobilization (1)
Recently bedridden or major surgery (1)
Localized tenderness (1)
Entire leg swollen (1)
Calf swelling >3 cm (1)
Pitting edema in symptomatic leg (1)
Collateral veins (1)
Previous DVT (1)
Alternative diagnosis as likely as DVT (-2)
Interpretation:

Score ≥2: DVT likely; Score ≤1: DVT unlikely.
Management:

If DVT likely (≥2):

Ultrasound within 4 hours.
Positive: initiate anticoagulation (DOACs preferred).
Negative: perform D-dimer; negative results suggest alternative diagnoses.
If ultrasound delayed >4 hours, give interim anticoagulation (low-molecular weight heparin) until the scan.
If D-dimer is positive after negative ultrasound, stop anticoagulation and repeat ultrasound in 6-8 days.
If DVT unlikely (≤1):

D-dimer test within 4 hours.
If negative, consider alternatives.
If positive, ultrasound within 4 hours; if delayed, initiate anticoagulation.
D-dimer Testing:

NICE recommends point-of-care or lab tests with age-adjusted cut-offs for patients >50 years.

243
Q

What are the possible differential diagnoses for DVT, including their similarities and differences?

A

Cellulitis:

Cause: Staphylococci or Streptococci infection.
Risk Factors: Diabetes, lymphoedema, IV drug use, chronic venous insufficiency.
Similarities: Unilateral erythema, swelling, pain, warmth.
Differences: Often has fever and raised inflammatory markers.

Superficial Thrombophlebitis:

Cause: Inflammatory response in a superficial vein.
Similarities: Pain and erythema.
Differences: Oedema and erythema are localized, with a palpable thrombus.
Dependent Oedema:

Similarities: Pitting oedema may occur.
Differences: Usually bilateral and worse at day’s end.

Liver Cirrhosis/Nephrotic Syndrome:

Similarities: Common leg oedema (hypoalbuminaemia) and possible erythema.
Differences: Symptoms are typically bilateral.

Ruptured Baker’s Cyst:

History: Swelling behind the knee.
Similarities: Pain in the calf.
Differences: Bruising below the medial malleolus (crescent sign).
Trauma:

Includes: Leg fractures, calf haematoma.
Note: Should be evident from the history.

244
Q

What are the key principles in the management of venous thromboembolism (VTE) and the use of anticoagulants?

A

Anticoagulant Therapy: The cornerstone of VTE management. Historically, warfarin was used with heparin; now, DOACs (apixaban, rivaroxaban) are preferred first-line.

Active Cancer: Use a DOAC unless contraindicated.
Renal Impairment: Use LMWH or unfractionated heparin if severe.
Antiphospholipid Syndrome: LMWH followed by a VKA is recommended.
Duration: Minimum 3 months; longer for unprovoked VTE. The decision to continue depends on VTE recurrence risk and bleeding risk (assessed with the HAS-BLED score).

245
Q

What are the common types of leg ulcers, and how do arterial and venous ulcers differ?

A

Leg ulcers are slow-healing skin breaks that can worsen over time. The common types include:

Venous Ulcers: Caused by blood pooling due to venous insufficiency.
Arterial Ulcers: Result from insufficient blood supply due to peripheral arterial disease.
Mixed Ulcers: Involve both arterial and venous pathology.

246
Q

What are the distinguishing features of arterial and venous ulcers?

A

Typically, arterial ulcers:

Occur distally, affecting the toes or dorsum of the foot
Are associated with peripheral arterial disease, with absent pulses, pallor and intermittent claudication
Are smaller than venous ulcers
Are deeper than venous ulcers
Have well defined borders
Have a “punched-out” appearance
Are pale colour due to poor blood supply
Are less likely to bleed
Are painful
Have pain worse at night (when lying horizontally)
Have pain is worse on elevating and improved by lowering the leg (gravity helps the circulation)

Typically, venous ulcers:

Occur in the gaiter area (between the top of the foot and bottom of the calf muscle)
Are associated with chronic venous changes, such as hyperpigmentation, venous eczema and lipodermatosclerosis
Occur after a minor injury to the leg
Are larger than arterial ulcers
Are more superficial than arterial ulcers
Have irregular, gently sloping border
Are more likely to bleed
Are less painful than arterial ulcers
Have pain relieved by elevation and worse on lowering the leg

247
Q

What investigations are used for assessing arterial and venous ulcers?

A

Ankle-Brachial Pressure Index (ABPI): Assesses arterial disease in both types of ulcers.

Blood Tests:
Full Blood Count (FBC) and C-reactive protein (CRP) to check for infection.
HbA1c for diabetes, FBC for anaemia, and albumin for malnutrition to assess co-morbidities.

Charcoal Swabs: Useful for identifying the causative organism if infection is suspected.

Skin Biopsy: Required if skin cancer (e.g., squamous cell carcinoma) is suspected; involves a two-week wait referral to dermatology.

248
Q

How are arterial ulcers managed?

A

–> Urgent Referral: Refer to vascular specialists for evaluation of surgical revascularization.
–> Treat Underlying Disease: Effective management of peripheral arterial disease leads to rapid healing of ulcers.
–> Avoid Debridement and Compression: These techniques are not appropriate for arterial ulcers.

249
Q

What is the management approach for venous ulcers according to NICE CKS?

A

Referral to Vascular Surgery: If mixed or arterial ulcers are suspected.
Tissue Viability/Specialist Clinics: For complex or non-healing ulcers.
Dermatology Referral: If alternative diagnoses like skin cancer are suspected.
Pain Clinics: For difficult pain management.
Diabetic Ulcer Services: For patients with diabetic ulcers.

250
Q

What are the key components of managing venous ulcers based on NICE CKS guidelines?

A

–> Referral Needs:
Vascular surgery for mixed/arterial ulcers.
Tissue viability clinics for complex ulcers.
Dermatology for suspected skin cancer.
Pain clinics for pain management.
Diabetic ulcer services for diabetic patients.
–> Wound Care:
Clean and debride the wound.
Dress the wound appropriately.
–> Compression Therapy: After excluding arterial disease (using ABPI).
–> Medications:
Pentoxifylline for healing (not licensed).
Antibiotics for infection.
Analgesia (avoid NSAIDs).

251
Q

What is cardiac arrest, and what are its immediate concerns?

A

Cardiac arrest is when the heart stops beating, leading to the absence of cardiac contractions. While there may be pulseless electrical activity (PEA), irreversible brain damage can occur in less than 5 minutes. Performing CPR aims to maintain cardiac output through chest compressions, ultimately seeking return of spontaneous circulation (ROSC) when the heart resumes beating.

252
Q

What are the 5 H’s and 4 T’s that can cause reversible cardiac arrest?

A

The causes of reversible cardiac arrest include:
H’s:

Hypoxia
Hypovolaemia
Hypokalaemia
Hyperkalaemia
Hypothermia

T’s:
Tension pneumothorax
Tamponade (cardiac)
Toxins
Thrombosis

253
Q

What is the compression-to-breath ratio in CPR?

A

30 chest compressions followed by 2 breaths.

254
Q

Where should the pads of a defibrillator be placed?

A

One pad under the right clavicle and the other at the apex beat.

255
Q

What are shockable rhythms?

A

Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF).

256
Q

When should you administer adrenaline during cardiac arrest?

A

After the first shock for shockable rhythms and immediately for non-shockable rhythms.

257
Q

What is the purpose of administering atropine in ALS?

A

To help reset the heart rhythm; give 3 mg at the start of ALS

258
Q

What is Acute Heart Failure (AHF)?

A

AHF is a life-threatening emergency characterized by the sudden onset or worsening of heart failure symptoms.

259
Q

What are the two types of Acute Heart Failure?

A

De-novo AHF (no prior history of heart failure) 2. Decompensated AHF (history of heart failure).

260
Q

What is de-novo Acute Heart Failure?

A

AHF that occurs without a background history of pre-existing heart failure.

261
Q

What typically causes Acute Heart Failure?

A

AHF is usually caused by reduced cardiac output resulting from functional or structural abnormalities of the heart.

262
Q

What causes de-novo Acute Heart Failure?

A

It is caused by increased cardiac filling pressures and myocardial dysfunction, often due to ischemia, leading to reduced cardiac output and hypoperfusion.

263
Q

What can result from reduced cardiac output in de-novo AHF?

A

Reduced cardiac output can lead to pulmonary oedema.

264
Q

What are some less common causes of de-novo Acute Heart Failure?

A
  1. Viral myopathy 2. Toxins 3. Valve dysfunction.
265
Q

What are the most common precipitating causes of decompensated Acute Heart Failure?

A
  1. Acute coronary syndrome
  2. Hypertensive crisis (e.g., bilateral renal artery stenosis)
  3. Acute arrhythmia
  4. Valvular disease.
266
Q

How does decompensated heart failure typically present?

A

It usually presents with signs of fluid congestion, weight gain, orthopnea, and breathlessness, often in patients with a history of pre-existing cardiomyopathy.

267
Q

What are the common symptoms of acute heart failure?

A

–> breathlessness
–> Reduced excercise tolerance
–> Oedema
–> Fatigue

268
Q

What are the common signs of acute heart failure?

A

–> cyanosis
–> tachycardia
–> elevated JVP
–> displaced apex beat
–> chest signs: classically bibasal crackles but may also cause a wheeze
–> S3 - heart sound

Sometimes the presentation will be that of the underlying cause (e.g: chest pain, viral infection)

Over 90% of patients with AHF have a normal or increased blood pressure (mmHg).

269
Q

What is included in the diagnostic workup for Acute Heart Failure?

A

–> Blood Tests: To identify underlying abnormalities such as anaemia, abnormal electrolytes, or infection or troponin for MI.
–> Chest X-ray: Findings may include pulmonary venous congestion, interstitial oedema, and cardiomegaly. ABCDE
–> Echocardiogram: Used to identify pericardial effusion/ cardiac tamponade/ LV ejection fraction >50% is normal.
–> B-type Natriuretic Peptide (BNP): Raised levels (>100 mg/litre) indicate myocardial damage and support the diagnosis.
–> ECG - assess for ischaemia and arrhythmias

270
Q

What are the sensitivity and specificity characteristics of B-type Natriuretic Peptide (BNP) in diagnosing heart failure, and what other conditions can cause elevated BNP levels?

A

Sensitivity:
BNP is sensitive for diagnosing heart failure; a negative result helps rule out heart failure.

Specificity:
BNP is not specific; elevated levels can occur in conditions other than heart failure, including:
Tachycardia
Sepsis
Pulmonary Embolism
Renal Impairment
Chronic Obstructive Pulmonary Disease (COPD)

271
Q

What are the CXR findings in acute heart failure?

A

A: alveolar oedema (perihilar/bat-wing opacification)
B: Kerley B lines (interstitial oedema)
C: cardiomegaly (cardiothoracic ratio >50%) – may be difficult to assess on an AP film
D: dilated upper lobe vessels
E: effusions (i.e. pleural effusions – blunted costophrenic angles with meniscus sign)

272
Q

What are the management options for Acute Heart Failure?

A

Hospital Admission: Patients require admission, especially those with severe pulmonary oedema or cardiogenic shock, potentially to high dependency or intensive care units. Involve experienced seniors early.

Mnemonic: SODIUM

S – Sit Up: Helps oxygenate the lungs; reduces fluid spread.
O – Oxygen: Administer for saturation < 95%; target 88-92% for COPD.
D – Diuretics: IV furosemide to increase urine output and reduce fluid volume.
I – IV Fluids Should Be Stopped: Avoid fluid overload.
U – Underlying Causes Need Treatment: Identify and treat causes like myocardial infarction.
M – Monitor Fluid Balance: Track intake/output, U&Es, and body weight.
Severe Cases May Require:

IV Opiates: Such as morphine (vasodilators).
IV Nitrates: For severe hypertension or acute coronary syndrome.
Inotropes: Dobutamine to improve cardiac output.
Vasopressors: Noradrenaline to improve blood pressure.
Non-Invasive Ventilation: Support breathing.
Invasive Ventilation: Intubation and sedation if necessary.
Key Points:

Inotropes: Increase heart contractility, cardiac output, and mean arterial pressure (MAP).
Vasopressors: Cause vasoconstriction, increase systemic vascular resistance, and improve MAP for better tissue perfusion.

273
Q

What is chronic heart failure, and how is it characterised in terms of left ventricular function and ejection fraction?

A

Definition: Chronic heart failure refers to the clinical features of impaired heart function, specifically the left ventricle’s ability to pump blood effectively.

Pathophysiology:

Impaired left ventricular function leads to a backlog of blood, increasing volume and pressure in the left atrium, pulmonary veins, and lungs.
This can result in pulmonary oedema due to fluid leakage and inability to reabsorb excess fluid from surrounding tissues.
Ejection Fraction:

Normal Ejection Fraction: >50%
Heart Failure with Reduced Ejection Fraction: EF < 50%
Heart Failure with Preserved Ejection Fraction: Clinical features of heart failure with EF > 50%, often due to diastolic dysfunction (issues with filling during diastole).

274
Q

What are the causes of chronic heart failure?

A

Ischaemic heart disease
Valvular heart disease (commonly aortic stenosis)
Hypertension
Arrhythmias (commonly atrial fibrillation)
Cardiomyopathy

275
Q

What is the presentation of someone with chronic heart failure?

A

Breathlessness, worsened by exertion
Cough, which may produce frothy white/pink sputum
Orthopnoea, which is breathlessness when lying flat, relieved by sitting or standing (ask how many pillows they use)
Paroxysmal nocturnal dyspnoea
Peripheral oedema
Fatigue

276
Q

What signs would there be on clinical examination for chronic heart failure?

A

Tachycardia (raised heart rate)
Tachypnoea (raised respiratory rate)
Hypertension
Murmurs on auscultation indicating valvular heart disease
3rd heart sound on auscultation
Bilateral basal crackles (sounding “wet”) on auscultation of the lungs, indicating pulmonary oedema
Raised jugular venous pressure (JVP), caused by a backlog on the right side of the heart, leading to an engorged internal jugular vein in the neck
Peripheral oedema of the ankles, legs and sacrum

277
Q

What are the investigations for chronic heart failure?

A

–> Clinical assessment - Hx and examination
–> NT-proBNP bloods
–> ECG
–> Echocardiogram
–> Bloods - to look for anaemia, renal function, thyroid function, liver function, lipids and diabetes
–> chest X-ray and lung function tests to exclude lung pathology

278
Q

What are the five principles of management for chronic heart failure?

A

R – Refer to cardiology
A – Advise them about the condition
M – Medical treatment
P – Procedural or surgical interventions
S – Specialist heart failures MDT input, such as the heart failure specialist nurses, for advice and support

279
Q

What is the medical treatment for chronic heart failure?

A

A – ACE inhibitor (e.g., ramipril) titrated as high as tolerated
B – Beta blocker (e.g., bisoprolol) titrated as high as tolerated
A – Aldosterone antagonist when symptoms are not controlled with A and B (e.g., spironolactone or eplerenone)
L – Loop diuretics (e.g., furosemide or bumetanide)

additional specialist treatments - SGLT2 inhibitor (e.g., dapagliflozin)
Sacubitril with valsartan (brand name Entresto)
Ivabradine
Hydralazine with a nitrate
Digoxin

280
Q

What is the procedural and surgical interventions for chronic heart failure?

A

–> can treat underlying valvular heart disease
–> Implantable cardioverter defibrillators - for patients who have had ventricular tachycardia or V fib before
–> Cardiac resynchronization therapy CRT - severe heart failure with EF < 35%, involves bi-ventricular pacemakers - leads to the right atrium and both ventricles - aim to synchronise the contractions
–> heart transplant in severe disease

281
Q

What is hypertrophic obstructive cardiomyopathy (HOCM), and what are its characteristics and implications?

A

Definition: Cardiomyopathy refers to disorders of the heart muscle. HOCM is a condition where the left ventricle becomes hypertrophic, leading to thickening of the muscle.

Key Features:

Asymmetric thickening, particularly affecting the septum, causes left ventricular outflow tract (LVOT) obstruction.
Associated with an increased risk of:
Heart failure
Myocardial infarction
Arrhythmias
Sudden cardiac death (often during exertion)
Epidemiology:

Autosomal dominant genetic condition caused by defects in sarcomere protein genes.
Prevalence: Approximately 1 in 500 people.

282
Q

What are the presentation and examination findings of hypertrophic obstructive cardiomyopathy (HOCM)?

A

–> Presentation:
Most patients are asymptomatic.
Non-specific symptoms may occur during exertion:

–> Shortness of breath
–> Fatigue
–> Dizziness
–> Syncope
–> Chest pain
–> Palpitations

Severe cases may present with symptoms of heart failure:
–> Cough
–>Shortness of breath
–>Orthopnoea
–> Paroxysmal nocturnal dyspnoea
–> Oedema
–> Family History: Important to ask about a family history of heart disease and sudden death. HOCM can occur in patients without a family history due to de novo mutations.

–> Examination Findings:

–> Ejection systolic murmur at the lower left sternal border (louder with Valsalva manoeuvre)
–> Fourth heart sound
–> Thrill at the lower left sternal border

Possible signs of:
–> Atrial fibrillation (irregularly irregular pulse)
–> Mitral regurgitation (high-pitched, pan-systolic murmur)
–> Heart failure

283
Q

What investigations are used to diagnose hypertrophic obstructive cardiomyopathy (HOCM)?

A

ECG: May show left ventricular hypertrophy.
Chest X-ray: Usually normal; may show signs of pulmonary oedema if heart failure is present.
Echocardiogram/Cardiac MRI: Used to establish the diagnosis.
Genetic Testing: May be considered to identify affected genes.

284
Q

What are the management options for hypertrophic obstructive cardiomyopathy (HOCM)?

A

Management Options:

Beta blockers
Surgical myectomy (removing part of the heart muscle to relieve obstruction)
Alcohol septal ablation (minimally invasive procedure to shrink obstructive tissue)
Implantable cardioverter defibrillator (for those at risk of sudden cardiac death or ventricular arrhythmias)
Heart transplant
Patient Advice:

Avoid intense exercise, heavy lifting, and dehydration.
ACE inhibitors and nitrates are avoided as they can worsen LVOT obstruction.
Genetic counselling offered; relatives may be tested.

285
Q

What are the potential outcomes and complications associated with hypertrophic obstructive cardiomyopathy (HOCM)?

A

Outcomes:
Minimal symptoms with a normal lifespan (most patients)
Complications:
Arrhythmias (e.g., atrial fibrillation)
Mitral regurgitation
Heart failure
Sudden cardiac death

286
Q

What are the different types of cardiomyopathy and their characteristics other than hypertrophiic obstructive cardiomyopathy?

A

Dilated Cardiomyopathy: Heart muscle becomes thin and dilated; may be genetic or secondary to conditions like myocarditis.

Alcohol-Induced Cardiomyopathy: A type of dilated cardiomyopathy caused by long-term alcohol use.

Restrictive Cardiomyopathy: Heart muscle becomes rigid and stiff, impairing ventricular filling during diastole.

Arrhythmogenic Cardiomyopathy: Genetic condition where heart muscle is replaced with fibrofatty tissue, leading to ventricular arrhythmias; a notable cause of sudden cardiac death in young people.

Takotsubo Cardiomyopathy: Rapid onset of left ventricular dysfunction often following severe emotional stress (known as “broken heart syndrome”); tends to resolve spontaneously.

287
Q

What is Peripheral Arterial Disease (PAD) and its associated conditions?

A

Definition: PAD is the narrowing of arteries supplying the limbs, usually affecting the lower limbs, which reduces blood supply.

Intermittent Claudication:

A symptom of ischaemia in a limb.
Occurs during exertion and is relieved by rest.
Typically presents as crampy, achy pain in the calf, thigh, or buttock, with muscle fatigue when walking beyond a certain intensity.
Critical Limb Ischaemia:

End-stage PAD with inadequate blood supply for normal function at rest.
Features: pain at rest, non-healing ulcers, gangrene.
Pain is worse at night when the leg is raised.
Acute Limb Ischaemia:

Rapid onset of ischaemia due to a thrombus blocking arterial supply.
Similar to a thrombus in coronary artery leading to myocardial infarction.

288
Q

What is intermittent claudication?

A

A symptom of ischaemia in a limb.
Occurs during exertion and is relieved by rest.
Typically presents as crampy, achy pain in the calf, thigh, or buttock, with muscle fatigue when walking beyond a certain intensity.

289
Q

What is critical limb ischaemia?

A

End-stage PAD with inadequate blood supply for normal function at rest.
Features: pain at rest, non-healing ulcers, gangrene.
Pain is worse at night when the leg is raised.

290
Q

What is acute limb ischaemia?

A

Rapid onset of ischaemia due to a thrombus blocking arterial supply.
Similar to a thrombus in coronary artery leading to myocardial infarction.

291
Q

What is Atherosclerosis and how does it affect the cardiovascular system?

A

Definition: Atherosclerosis is the hardening of arteries caused by the accumulation of atheromas (fatty deposits) and chronic inflammation in medium and large arteries.

Athero-: Refers to soft or porridge-like.
-Sclerosis: Refers to hardening or stiffening of blood vessel walls.
Pathophysiology:

Chronic inflammation activates the immune system in the artery wall.
Lipids are deposited, leading to fibrous atheromatous plaque development.
Effects of Atherosclerosis:

Stiffening of Artery Walls: Leads to hypertension (raised blood pressure) and increased strain on the heart.
Stenosis: Narrowing of arteries reduces blood flow, potentially causing conditions like angina.
Plaque Rupture: Can result in thrombus formation, blocking distal vessels and causing ischaemia (e.g., in acute coronary syndrome).

292
Q

What are the risk factors for Atherosclerosis, and how are they categorised?

A

Non-Modifiable Risk Factors (Cannot be changed):

–> Older Age: Increased age is associated with higher risk.
–> Family History: Genetics can play a significant role in risk.
–> Male Gender: Males are generally at higher risk compared to females.

–> Modifiable Risk Factors (Can be changed):
–> Smoking: Increases plaque formation and vascular damage.
–> Alcohol Consumption: Excessive intake can contribute to hypertension and lipid abnormalities.
–> Poor Diet: Diets high in sugar and trans-fats and low in fruits, vegetables, and omega-3 fatty acids.
–> Low Exercise/Sedentary Lifestyle: Lack of physical activity is linked to obesity and cardiovascular risk.
–> Obesity: Excess body weight contributes to hypertension and dyslipidemia.
–> Poor Sleep: Sleep disturbances can affect cardiovascular health.
–> Stress: Chronic stress may contribute to unhealthy behaviors and directly affect heart health.

293
Q

What medical co-morbidities increase the risk of atherosclerosis, and why is their management important?

A

The following medical co-morbidities increase the risk of atherosclerosis and should be carefully managed:

–> Diabetes: Hyperglycemia can damage blood vessels and accelerate atherosclerosis.
–> Hypertension: Elevated blood pressure contributes to vascular damage and plaque formation.
–> Chronic Kidney Disease: Impaired kidney function can lead to fluid and electrolyte imbalances that affect heart health.
–> Inflammatory Conditions: Conditions such as rheumatoid arthritis can increase systemic inflammation, promoting atherosclerosis.
–> Atypical Antipsychotic Medications: These medications can cause weight gain and metabolic syndrome, increasing cardiovascular risk.

294
Q

What are the potential end results of atherosclerosis?

A

–> Angina: Chest pain due to reduced blood flow to the heart muscle.
–> Myocardial Infarction: Heart attack caused by complete blockage of blood flow to a part of the heart.
–> Transient Ischaemic Attack (TIA): Temporary disruption of blood flow to the brain, resulting in stroke-like symptoms that resolve within 24 hours.
–> Stroke: Permanent damage due to prolonged lack of blood flow to the brain.
Peripheral Arterial Disease (PAD): Narrowing of arteries supplying the limbs, leading to claudication and critical limb ischaemia.
–> Chronic Mesenteric Ischaemia: Insufficient blood flow to the intestines, causing abdominal pain and weight loss.

295
Q

What is intermittent claudication and how does it present in patients with peripheral arterial disease?

A

Intermittent claudication is a symptom of peripheral arterial disease characterised by:

Description: Crampy pain that occurs predictably after walking a certain distance.
Location: Most commonly in the calf muscles, but can also affect the thighs and buttocks.
Relief: Pain disappears after stopping and resting.

296
Q

What are the features of acute limb ischaemia and how can they be remembered?

A

The features of acute limb ischaemia can be remembered using the “6 P’s” mnemonic:

Pain
Pallor
Pulseless
Paralysis
Paraesthesia (abnormal sensation or “pins and needles”)
Perishing cold

297
Q

What is Leriche syndrome and what are its clinical features?

A

Leriche syndrome occurs due to occlusion in the distal aorta or proximal common iliac artery, presenting with a clinical triad of:

Thigh/buttock claudication
Absent femoral pulses
Male impotence

298
Q

What risk factors and signs of cardiovascular disease should be looked for during examination in patients with Peripheral Arterial Disease (PAD)?

A

Risk Factors:

Tar staining on the fingers
Xanthomata (yellow cholesterol deposits on the skin)

Signs of Cardiovascular Disease:
Missing limbs or digits after previous amputations
Midline sternotomy scar (previous CABG)
Scar on the inner calf for saphenous vein harvesting (previous CABG)
Focal weakness suggestive of a previous stroke

299
Q

Which peripheral pulses should be assessed in a patient with Peripheral Arterial Disease, and how can you enhance this assessment?

A

–> Radial
–> Brachial
–> Carotid
–> Abdominal aorta
–> Femoral
–> Popliteal
–> Posterior tibial
–> Dorsalis pedis

300
Q

What signs of arterial disease may be observed on inspection during an examination?

A

Skin pallor
Cyanosis
Dependent rubor (deep red color when the limb is lower)
Muscle wasting
Hair loss
Ulcers
Poor wound healing
Gangrene (dark red/black color change in the skin)

301
Q

What examination findings may indicate arterial disease in a patient with Peripheral Arterial Disease?

A

Reduced skin temperature
Reduced sensation
Prolonged capillary refill time (more than 2 seconds)
Changes during Buerger’s test

302
Q

What is Buerger’s test and what is its purpose?

A

Buerger’s test is used to assess for peripheral arterial disease (PAD) in the leg. It consists of two parts that evaluate the adequacy of blood supply to the legs when subjected to gravitational changes.

303
Q

Describe the first part of Buerger’s test and its significance.

A

In the first part, the patient lies supine, and the legs are lifted to an angle of 45 degrees at the hip for 1-2 minutes. Pallor indicates inadequate arterial supply to overcome gravity, suggesting peripheral arterial disease.

304
Q

Describe the second part of Buerger’s test and the expected findings.

A

In the second part, the patient is seated with legs hanging over the side of the bed. Blood returns to the legs due to gravity:

In a healthy patient, the legs remain a normal pink color.
In a patient with PAD, the legs initially turn blue due to deoxygenated blood from ischaemic tissue, then dark red due to vasodilation in response to anaerobic respiration waste products.

305
Q

What does the term “rubor” refer to in the context of Buerger’s test?

A

Rubor refers to the dark red color observed in the legs of a patient with peripheral arterial disease after they have been hanging down, indicating a response to ischaemia and vasodilation.

306
Q

What are the main Investigations to diagnose Peripheral Arterial Disease?

A

–> Ankle-Brachial Pressure Index (ABPI)
–> Duplex ultrasound (assessing speed and volume of blood flow)
–> Angiography (CT or MRI using contrast to highlight arterial circulation)

307
Q

What does the Ankle-Brachial Pressure Index (ABPI) measure?

A

–> ABPI measures the ratio of systolic blood pressure (SBP) in the ankle to the systolic blood pressure in the arm, providing an assessment of blood flow to the lower limbs.

308
Q

How is the Ankle-Brachial Pressure Index (ABPI) measured?

A

ABPI is measured manually using a Doppler probe. For example, if the ankle SBP is 80 mmHg and the arm SBP is 100 mmHg, the ABPI is calculated as 0.8 (80/100).

309
Q

What is considered a normal range for the Ankle-Brachial Pressure Index (ABPI)?

A

An ABPI of 0.9 to 1.3 is considered normal.

310
Q

What does an ABPI of 0.6 to 0.9 indicate?

A

An ABPI of 0.6 to 0.9 indicates mild peripheral arterial disease.

311
Q

What does an ABPI of 0.3 to 0.6 indicate?

A

An ABPI of 0.3 to 0.6 indicates moderate to severe peripheral arterial disease.

312
Q

What does an ABPI of less than 0.3 indicate?

A

An ABPI of less than 0.3 indicates severe disease or critical ischaemia.

313
Q

What does an ABPI above 1.3 indicate?

A

An ABPI above 1.3 may indicate calcification of the arteries, making them difficult to compress, which is more common in diabetic patients.

314
Q

What lifestyle changes are recommended for managing intermittent claudication?

A

Stopping smoking
Optimising medical treatment of co-morbidities (e.g., hypertension and diabetes)
Engaging in a structured exercise training program

315
Q

What does the exercise training program for intermittent claudication involve?

A

The exercise training program involves regularly walking to the point of near-maximal claudication pain, then resting and repeating the process.

316
Q

What medical treatments are commonly used for intermittent claudication?

A

Atorvastatin 80 mg
Clopidogrel 75 mg once daily (aspirin if clopidogrel is unsuitable)
Naftidrofuryl oxalate (a 5-HT2 receptor antagonist that acts as a peripheral vasodilator)

317
Q

What surgical options are available for managing intermittent claudication?

A

Endovascular angioplasty and stenting
Endarterectomy (removing the atheromatous plaque)
Bypass surgery (using a graft to bypass the blockage)

318
Q

How should patients with critical limb ischaemia be managed?

A

Patients require urgent referral to the vascular team and analgesia to manage pain.

319
Q

What are the urgent revascularisation options for critical limb ischaemia?

A

Endovascular angioplasty and stenting
Endarterectomy
Bypass surgery
Amputation of the limb if blood supply cannot be restored

320
Q

What is the management priority for patients with acute limb ischaemia?

A

Patients require an urgent referral to the on-call vascular team for assessment.

321
Q

According to the 2022 NICE guidelines, what are the blood pressure thresholds for diagnosing hypertension?

A

In the clinical setting, hypertension is diagnosed with blood pressure above 140/90 mmHg.
Confirmation is required with ambulatory or home readings above 135/85 mmHg.

322
Q

What are the primary and secondary causes of hypertension, and how can the secondary causes be remembered?

A

Primary (essential) hypertension accounts for 90% of cases and occurs without a secondary cause.
Secondary causes can be remembered with the mnemonic ROPED:
R: Renal disease/ renal artery stenosis
O: Obesity
P: Pregnancy-induced hypertension or pre-eclampsia
E: Endocrine (e.g., hyperaldosteronism)
D: Drugs (e.g., alcohol, steroids, NSAIDs, oestrogen, liquorice)

323
Q

What are the main risks associated with high blood pressure?

A

–> Ischaemic heart disease (angina, acute coronary syndrome)
–> Cerebrovascular accident (stroke, intracranial haemorrhage)
–> Vascular disease (peripheral arterial disease, aortic dissection, aortic aneurysms)
–> Hypertensive retinopathy
–> Hypertensive nephropathy
–> Vascular dementia
–> Left ventricular hypertrophy
–> Heart failure

324
Q

What mechanisms contribute to the development of hypertension?

A

Genetic: RAAS gene polymorphisms.
Neural: Increased sympathetic activity.
Renal: Impaired sodium/water balance and RAAS abnormalities.
Endocrine: RAAS dysregulation (↑ Angiotensin II, aldosterone), endothelial dysfunction (↓ Nitric oxide, ↑ Endothelin-1).
Vascular: Arterial stiffness, impaired vasodilation.
Lifestyle: Obesity, high salt, alcohol, inactivity.

325
Q

What are the possible symptoms of very high blood pressure, and how is hypertension assessed?

A

Symptoms (if BP > 200/120 mmHg): Headaches, visual disturbance, seizures.
Signs: Detected by measuring blood pressure; 24-hour monitoring avoids “white coat” hypertension and is more reliable for guiding treatment.
Assessment:
Fundoscopy: Hypertensive retinopathy.
Urine dipstick: Renal disease.
ECG: Left ventricular hypertrophy, ischaemic heart disease.

326
Q

What tests are typically done after diagnosing hypertension?

A

Urea and electrolytes: Check for renal disease.
HbA1c: Screen for diabetes mellitus.
Lipids: Assess for hyperlipidaemia.
ECG: Evaluate heart function.
Urine dipstick: Check for kidney involvement.
24-Hour BP Monitoring: Recommended for diagnosis. If unavailable, home readings with an automated sphygmomanometer are useful.

327
Q

What are the clinic and confirmed readings for the stages of hypertension?

A

Stage 1 Hypertension:
Clinic: > 140/90
Home/24-hr: > 135/85
Stage 2 Hypertension:
Clinic: > 160/100
Home/24-hr: > 150/95
Stage 3 Hypertension (Severe):
Clinic: > 180/120

328
Q

What investigations are recommended by NICE for patients with newly diagnosed hypertension?

A

Urine tests: Albumin
ratio & dipstick for proteinuria/haematuria (kidney damage)
Bloods: HbA1c, renal function, lipids
Fundus exam: Hypertensive retinopathy
ECG: Check for left ventricular hypertrophy or other cardiac abnormalities
QRISK score: >10% = offer atorvastatin 20mg

329
Q

What are the key steps for diagnosing and managing hypertension according to NICE guidelines?

A

Initial Assessment:
Measure BP in both arms. If >20 mmHg difference, repeat and use the higher reading for further assessments.

Take a second reading if the first is >140/90 mmHg; use the lower reading for management.

Blood Pressure Monitoring:
Offer ABPM for BP ≥140/90 mmHg:
At least 2 measurements/hour during waking hours, average at least 14 readings.

If ABPM is declined, offer HBPM:
Two consecutive measurements, at least 1 minute apart, twice daily for 4-7 days (discard day 1).

Treatment Thresholds:
ABPM/HBPM ≥135/85 mmHg: Treat if <80 years with target organ damage, CVD, renal disease, diabetes, or 10-year cardiovascular risk ≥10%.

Consider treatment for those under 60 with stage 1 hypertension and estimated 10-year risk <10%.

Immediate Management:
For BP ≥180/110 mmHg: consider immediate treatment.

If papilloedema or retinal hemorrhages are present, refer for same-day assessment.
Referral for suspected phaeochromocytoma if symptomatic (labile BP, headaches, palpitations).

330
Q

Outline the stepwise management approach for hypertension based on patient characteristics.

A

Step 1:

With Type 2 Diabetes:
Start ACE inhibitor (rampiril) or Angiotensin Receptor Blocker (candersartan).
Without Type 2 Diabetes:
Aged <55 and not black African/African-Caribbean: Start ACEi or ARB.
Aged ≥55 or black African/African-Caribbean: Start Calcium Channel Blocker (amlodipine).
Step 2:

With Type 2 Diabetes:
Add CCB or thiazide-like diuretic (indapamide)
Without Type 2 Diabetes:
Add ACEi or ARB (if CCB was started) or thiazide-like diuretic.

Step 3:
Combine ACEi or ARB + CCB + thiazide-like diuretic.

Step 4:
Confirm resistant hypertension with ABPM or HBPM. Check for postural hypotension. Consider adding low-dose spironolactone if potassium level ≤4.5 mmol/L. Seek advice if BP is uncontrolled on optimal tolerated doses of 4 drugs.

331
Q

What are the blood pressure targets for different age groups using clinic BP and ABPM/HBPM?

A

Blood Pressure Targets:

Age < 80 years:

Clinic BP: <140/90 mmHg
ABPM/HBPM: <135/85 mmHg
Age > 80 years:

Clinic BP: <150/90 mmHg
ABPM/HBPM: <145/85 mmHg

332
Q

What is infective endocarditis?

A

Infective Endocarditis:

Refers to infection of the endothelium (inner surface) of the heart, most commonly affecting the heart valves.
Types:
Acute: Rapid onset of symptoms, often caused by aggressive organisms.
Subacute: Symptoms develop more gradually, usually associated with less virulent organisms.
Chronic: Symptoms persist over a longer period, typically with less severe manifestations.

333
Q

What are the individual and specific cardiac risk factors for developing infective endocarditis?

A

Patient Factors:

–> Age > 60 years
–> Gender: Male
–> Intravenous Drug Use: Increases risk of bloodstream infection; certain substances can damage endothelium. Higher risk of right-sided IE.
–> Intravascular Lines: Presence of catheters increases infection risk.
–> Chronic Hemodialysis: Often involves a fistula or long-term catheter that can become infected.
–> Immunosuppression: Conditions such as cancer or HIV, and use of immunosuppressive medications.
–> Recent Dental or Surgical Procedure: Poor dental hygiene can lead to the introduction of bacteria into the bloodstream during gingival manipulation or invasive procedures.

Cardiac Factors:
–> History of Prior Infective Endocarditis: Previous episodes increase risk.
–> Prosthetic Heart Valve or Cardiac Device: Presence of devices increases susceptibility to infection.
–> Structural Heart Disease: Includes valvular heart disease or congenital heart disease.

334
Q

What are the common causative organisms of infective endocarditis and how does the disease develop?

A

Common Microbial Causes of IE:

–> Staphylococcus: Most common in healthcare-associated IE.
–> Viridans Group Streptococcus: More prevalent in older populations and community-acquired IE.
–> Enterococci
–> Streptococcus bovis: Strongly associated with ulcerative lesions in the colon (e.g., carcinoma).

Pathophysiology of Infective Endocarditis:

–> Entry of Organisms: The causative organism enters the bloodstream via:
Infected catheters.
Breaks in the skin or mucous membranes.
–> Bacteraemia: Presence of bacteria in the bloodstream progresses to infective endocarditis in the context of:
Endocardial injury or damage (e.g., due to turbulent blood flow from dysfunctional valves or congenital abnormalities).
–> Development of Vegetation:
Endocardial Injury: Causes adherence of platelets and fibrin.
Circulating Micro-organisms: Lead to secondary infection of the fibrin plug.
Coagulation Cascade Activation: Further adherence of fibrin and platelets.
Vegetation Growth: Formation of a larger mass (vegetation) on the heart valves or endocardium.

335
Q

What are the clinical presentations and symptoms of infective endocarditis?

A

Infective endocarditis can present acutely or subacutely with the following symptoms:

Non-Specific Sinfectiveymptoms:

Fever (90%) with chills, anorexia, and weight loss
Malaise
Arthralgia
Myalgia
Night sweats
Abdominal pain
Clinical Signs:

Heart murmurs (85%, usually in left-sided IE)
Petechiae on extremities or mucous membranes (30%)
Splinter haemorrhages (reddish-brown linear lesions on nail bed)
Specific Findings:

Janeway lesions (non-tender macules on palms and soles, associated with acute onset)
Osler nodes (tender nodules on fingers and toes)
Roth spots (haemorrhagic retinal lesions with a pale center)
Complications:

Congestive heart failure
Systemic embolisation (e.g., embolic stroke)
Pulmonary septic emboli: Most common presentation (75%) of isolated right-sided IE, may present with cough, dyspnoea, haemoptysis, or pleuritic chest pain.

336
Q

What are the key diagnostic investigations for infective endocarditis?

A

Blood Cultures (Diagnostic):

At least 3 samples from different sites over 30-60 minutes are recommended.
Samples should be taken before starting any antibiotics to ensure accurate results.

Echocardiogram (Diagnostic):
Transthoracic Echocardiogram (TTE): Usually the first-line investigation.
Transoesophageal Echocardiogram (TOE): Preferred as the first-line if available due to its higher sensitivity for detecting left-sided IE and structural cardiac complications (e.g., intracardiac abscess, leaflet perforation, pseudoaneurysm).

Additional Investigations:
ECG: Identifies cardiac function issues such as heart block, conduction delay, and ischaemic changes (indicating emboli affecting coronary circulation).
Chest X-Ray: Looks for pulmonary septic emboli, congestive heart failure, and abscesses; helps exclude other differentials.
CT Scan (Thoracic, Abdominal, Pelvic): Useful for locating metastatic infections that may require drainage.

337
Q

What are the key considerations for effective antibiotic therapy and management in suspected infective endocarditis (IE)?

A

–> Empirical Therapy: If strong suspicion of IE and the patient is acutely unwell, start empirical antibiotics after obtaining adequate blood culture samples (amox and optional gent)
Choice of Antibiotics: Depends on:
Native valve
Prosthetic valve
People who inject drugs
If the patient is stable, antibiotic therapy may be delayed to select the most effective treatment based on culture results.
–> 2. Source of Infection:
Identify and Remove: Find and remove potentially removable sources of infection, such as:
Intravascular catheters
Intracardiac devices
Arteriovenous fistulas
Other Assessments:
Dental Evaluation: Identify and treat focal dental infections.
Colonoscopy: Particularly if Group D streptococci are identified, to evaluate for bowel lesions or cancer.
–> 3. Early Valve Surgery:
Indicated if complications arise, such as:
IE-associated valvular regurgitation/dysfunction
Heart failure
Intracardiac abscess
Persistent infection or difficult-to-treat organisms
–> 4. Follow-Up:
Echocardiogram (Echo): Recommended if there are clinical suspicions of complications (e.g., new murmurs, embolic events, heart failure, conduction abnormalities, persistent fever).
Post-antibiotic therapy, echo is advised to establish a new baseline (valve appearance, vegetation size, and heart function) as complete resolution of valvular vegetation is uncommon.
Frequency of follow-up depends on the individual’s new baseline.

338
Q

What are the Modified Duke Criteria used for diagnosing infective endocarditis (IE)?

A

Diagnosis Requirements:
One Major plus Three Minor Criteria
OR Five Minor Criteria

Major Criteria:
–> Persistently Positive Blood Cultures:
Typical bacteria identified on multiple cultures.
–> Specific Imaging Findings:
Presence of vegetations seen on echocardiogram.

Minor Criteria:
–> Predisposition:
Examples include intravenous drug use or existing heart valve pathology.
–> Fever:
Body temperature above 38°C.
–> Vascular Phenomena:
Examples include splenic infarction, intracranial hemorrhage, and Janeway lesions.
–> Immunological Phenomena:
Examples include Osler’s nodes, Roth spots, and glomerulonephritis.
–> Microbiological Phenomena:
Positive cultures that do not meet major criteria.

339
Q

What is mesenteric ischemia, and what causes it?

A

Mesenteric ischemia is caused by a lack of blood flow through the mesenteric vessels supplying the intestines, resulting in intestinal ischemia.

340
Q

What are the main branches of the abdominal aorta, and what regions do they supply?

A

Coeliac Artery:

Supplies the foregut, including:
Stomach
Part of the duodenum
Biliary system
Liver
Pancreas
Spleen
Superior Mesenteric Artery (SMA):

Supplies the midgut, from:
Distal part of the duodenum
To the first half of the transverse colon
Inferior Mesenteric Artery (IMA):

Supplies the hindgut, from:
Second half of the transverse colon
To the rectum

341
Q

What is chronic mesenteric ischaemia?

A

Chronic mesenteric ischaemia (intestinal angina) results from the narrowing of mesenteric blood vessels due to atherosclerosis, leading to intermittent abdominal pain.

342
Q

What is the classic triad of symptoms for chronic mesenteric ischaemia?

A

Central colicky abdominal pain after eating (starts ~30 minutes post-meal, lasting 1-2 hours)
Weight loss (due to food avoidance to prevent pain)
Abdominal bruit may be heard on auscultation

343
Q

What are the risk factors for chronic mesenteric ischaemia?

A

Increased age
Family history of cardiovascular disease
Smoking
Diabetes
Hypertension
Raised cholesterol levels

344
Q

How is chronic mesenteric ischaemia diagnosed?

A

Diagnosis is made through CT Angiography, which visualises the mesenteric blood vessels and identifies narrowing.

345
Q

What are the management strategies for chronic mesenteric ischaemia?

A

–> Reduce Modifiable Risk Factors:
Stop smoking
–> Secondary Prevention:
Statins and antiplatelet medications
–> Revascularisation:
Endovascular Procedures (First-line):
Percutaneous mesenteric artery stenting
–> Open Surgery:
Endarterectomy
Re-implantation
Bypass grafting

346
Q

What is acute mesenteric ischaemia?

A

Acute mesenteric ischaemia is a condition caused by a rapid blockage in blood flow through the superior mesenteric artery, typically due to a thrombus or embolus.

347
Q

What usually causes acute mesenteric ischaemia?

A

It is usually caused by a thrombus (blood clot) stuck in the artery, either formed within the artery or as an embolus that has migrated from another site.

348
Q

What is a key risk factor for acute mesenteric ischaemia?

A

Atrial fibrillation is a key risk factor, as a thrombus can form in the left atrium and then mobilize, leading to blockage in the superior mesenteric artery.

349
Q

How does acute mesenteric ischaemia typically present?

A

It presents with acute, non-specific abdominal pain that is disproportionate to the examination findings. Patients may develop shock, peritonitis, and sepsis.

350
Q

What can occur over time due to ischaemia of the bowel?

A

Prolonged ischaemia can lead to necrosis of the bowel tissue and perforation.

351
Q

What is the diagnostic test of choice for acute mesenteric ischaemia?

A

Contrast CT is the diagnostic test of choice, allowing assessment of both the bowel and blood supply.

352
Q

What laboratory findings are expected in acute mesenteric ischaemia?

A

Patients typically show metabolic acidosis and elevated lactate levels due to ischaemia.

353
Q

What are the two main surgical objectives in managing acute mesenteric ischaemia?

A

Remove necrotic bowel.
Remove or bypass the thrombus in the blood vessel, using either open surgery or endovascular procedures.

354
Q

What is mitral regurgitation (MR)?

A

Mitral regurgitation occurs when blood leaks back through the mitral valve during systole, leading to less efficient blood pumping and potential heart failure over time.

355
Q

What are the common causes of mitral regurgitation?

A

Causes include coronary artery disease, mitral valve prolapse, infective endocarditis, rheumatic fever, and congenital heart defects.

356
Q

What are the risk factors associated with mitral regurgitation?

A

Risk factors include female sex, lower body mass, age, renal dysfunction, prior myocardial infarction, prior mitral stenosis or valve prolapse, and collagen disorders (e.g., Marfan’s syndrome and ehlers danlos).

357
Q

What are the common symptoms of mitral regurgitation?

A

Most patients are asymptomatic; however, symptoms may include fatigue, shortness of breath, and edema due to left ventricle failure, arrhythmias, or pulmonary hypertension.

358
Q

What is the characteristic auscultation finding in mitral regurgitation?

A

A pansystolic “blowing” murmur heard best at the apex and radiating into the axilla; S1 may be quiet, and severe MR may cause a widely split S2.

359
Q

How is mitral regurgitation diagnosed?

A

Diagnosis involves ECG (may show broad P wave), chest X-ray (may show cardiomegaly enlarged left side), and echocardiography to assess the severity of regurgitation.

360
Q

What are the treatment options for mitral regurgitation?

A

Acute management may include nitrates, diuretics, positive inotropes, and intra-aortic balloon pump support; ACE inhibitors, beta-blockers, and spironolactone may be used for heart failure. Surgery is indicated for acute severe cases.

361
Q

What is the preferred surgical intervention for degenerative mitral regurgitation?

A

Surgical repair is preferred over replacement due to lower mortality and higher survival rates; valve replacement may be considered if repair is not possible.

362
Q

What is the primary cause of mitral stenosis (MS)?

A

The primary cause of mitral stenosis is a history of rheumatic fever, accounting for approximately 90% of cases.

363
Q

What are the causes of mitral stenosis (MS)?

A

–> Rheumatic Fever: The primary cause, resulting from an immune-mediated inflammatory response to group A streptococcal pharyngitis, leading to damage of the mitral valve leaflets and supporting structures.
–> Congenital Mitral Stenosis: Rare malformations of the mitral valve apparatus, such as parachute mitral valve, double-orifice mitral valve, and supravalvular ring.
–> Calcific Mitral Stenosis: Common in elderly patients, especially women, due to calcium deposition on the mitral annulus, resulting in decreased valve mobility.
–> Infective Endocarditis: Valvular destruction, scarring, or vegetation formation from infection that obstructs blood flow.
–> Other Causes: Conditions such as systemic lupus erythematosus, carcinoid syndrome, and mucopolysaccharidoses may contribute to mitral valve pathology, though less frequently.

364
Q

What are the physiological consequences of mitral stenosis (MS)?

A

Obstructed Blood Flow: MS obstructs blood flow from the left atrium to the left ventricle during diastole, leading to increased left atrial pressure.
Left Atrial Enlargement: The increased pressure causes left atrial enlargement, which predisposes patients to atrial fibrillation.
Pulmonary Hypertension: Elevated left atrial pressure results in pulmonary venous hypertension, leading to pulmonary arterial hypertension.
Right Ventricular Changes: This causes right ventricular hypertrophy and dilation, which can progress to right-sided heart failure.
Impaired Cardiac Output: The reduced preload in the left ventricle impairs cardiac output, contributing to exercise intolerance.

365
Q

What are the clinical features of mitral stenosis (MS)?

A

–> Dyspnoea: Shortness of breath due to pulmonary venous hypertension.
–> Increased Left Atrial Pressure: Leads to pulmonary venous hypertension.
–> Haemoptysis: Can range from pink frothy sputum to sudden hemorrhage due to rupture of thin-walled bronchial veins.
Heart Sounds:
- Mid-Late Diastolic Murmur: Best heard during expiration.
- Loud S1: Due to increased left atrial pressure.
- Opening Snap: Indicates that mitral valve leaflets are still mobile.
Low Volume Pulse: Indicative of reduced cardiac output.
Malar Flush: Redness of the cheeks due to increased blood flow.
Atrial Fibrillation: Secondary to increased left atrial pressure leading to left atrial enlargement.

Features of Severe Mitral Stenosis:

Length of Murmur Increases: The murmur duration becomes longer.
Closer Opening Snap to S2: The opening snap occurs closer to the second heart sound (S2).

366
Q

What investigations are used to diagnose and assess mitral stenosis (MS)?

A
  1. Echocardiography:

Transthoracic Echocardiography (TTE):
Key investigation for diagnosing and assessing severity.
Direct visualization of the mitral valve.
Provides information on valve area, leaflet morphology, degree of calcification, subvalvular changes, and pressure gradients.
A valve area of less than 1.5 cm² indicates significant stenosis.
Transoesophageal Echocardiography (TOE):
Used if TTE images are suboptimal.
Helpful in identifying thrombus in the left atrium, especially in patients with atrial fibrillation.

  1. Electrocardiogram (ECG):

Signs of left atrial enlargement:
Bifid P wave (P mitrale) in lead II.
Broad, negative P wave in lead V1.
Advanced stages may show atrial fibrillation, right ventricular hypertrophy, or signs of pulmonary hypertension.

  1. Chest X-ray:

Can show cardiac enlargement (specifically left atrial enlargement).
Evidence of pulmonary venous congestion or pulmonary oedema.
Characteristic findings include straightening of the left heart border and elevation of the left main stem bronchus.

367
Q

What are the treatment options for mitral stenosis (MS)?

A
  1. Medical Therapy:

Diuretics:
Alleviate pulmonary congestion and peripheral oedema.
Rate Control:
Beta-blockers are used to manage atrial fibrillation.
Anticoagulation:
Warfarin is prescribed to prevent thromboembolic events in patients with atrial fibrillation.

  1. Percutaneous Balloon Valvuloplasty:

Indicated for symptomatic patients with severe mitral stenosis (valve area < 1.5 cm²) and favourable valve morphology.
Procedure involves balloon dilation of the mitral valve to alleviate stenosis.

  1. Surgical Intervention:

Indications include:
Severe symptomatic mitral stenosis not amenable to valvuloplasty.
Presence of left atrial thrombus.
Significant mitral regurgitation.
Surgical options include mitral valve repair or replacement.

368
Q

What are the complications of mitral stenosis (MS)?

A
  1. Atrial Fibrillation:
    Most common complication of MS.
    Increases the risk of thromboembolic events, such as stroke.
  2. Pulmonary Hypertension:
    Elevated pulmonary artery pressure can lead to right ventricular failure and cor pulmonale.
  3. Thromboembolism:
    Stasis of blood in the left atrium predisposes to thrombus formation, increasing the risk of systemic embolization.
  4. Infective Endocarditis:
    Damaged mitral valve leaflets are more susceptible to infection.
  5. Hemoptysis:
    Rupture of bronchial veins due to elevated pulmonary venous pressure may cause hemoptysis.
  6. Pregnancy Complications:
    MS may worsen during pregnancy due to increased blood volume and cardiac output, potentially leading to maternal and fetal complications.
369
Q

What is myocarditis and its main causes?

A

Myocarditis refers to inflammation of the myocardium and should be considered in younger patients presenting with chest pain.

Causes include:

Viral: Coxsackie B, HIV
Bacterial: Diphtheria, clostridia
Spirochaetes: Lyme disease
Protozoa: Chagas’ disease, toxoplasmosis
Autoimmune
Drugs: Doxorubicin

370
Q

What are the typical presentations of myocarditis?

A

Usually young patient with acute onset
Chest pain
Dyspnoea
Arrhythmias

371
Q

What investigations are done for myocarditis?

A

Blood tests:
↑ Inflammatory markers (99% of cases)
↑ Cardiac enzymes
↑ BNP
ECG:
Tachycardia
Arrhythmias
ST/T wave changes (e.g. ST-segment elevation, T wave inversion)

372
Q

How is myocarditis managed?

A

treatment of underlying cause: e.g. antibiotics for bacterial infections
Supportive treatment: for heart failure or arrhythmias

373
Q

What are the complications of myocarditis?

A

Heart failure
Arrhythmia, possibly leading to sudden death
Dilated cardiomyopathy (a late complication)

374
Q

What is pericardial effusion, and what are the different types of fluid that can accumulate?

A

Pericardial effusion is the accumulation of excess fluid within the pericardial sac. The fluid can be:

Transudate (low protein content)
Exudate (associated with inflammation)
Blood
Pus
Gas (associated with bacterial infections)

375
Q

What is the pathophysiology of pericardial effusion?

A

Pericardial effusion occurs when excess fluid fills the potential space in the pericardial cavity, creating inward pressure on the heart and making it difficult for the heart to expand during diastole. This may lead to pericardial tamponade, where the increased intra-pericardial pressure reduces cardiac output. Urgent draining required

376
Q

What are the causes of pericardial effusion?

A

Transudative effusion (increased venous pressure can reduce drainage from the pericardial cavity):
–> Congestive heart failure
–> Pulmonary hypertension
Exudative effusion (inflammatory causes):
–> Infection (e.g., tuberculosis, HIV, Coxsackievirus, Epstein–Barr virus)
–> Autoimmune conditions (e.g., SLE, RA)
–> Injury to the pericardium (e.g., post-MI, post-surgery)
–> Uraemia
–> Cancer
–> Medications (e.g., methotrexate)
–> Bleeding (e.g., rupture of the heart, aortic dissection)

377
Q

What are the clinical features of pericardial effusion?

A

Symptoms:
Chest pain
Shortness of breath
Fullness in the chest
Orthopnoea
Compression of nearby structures can cause hiccups (phrenic nerve), dysphagia (oesophagus) , or hoarse voice (recurrent laryngeal nerve)

Signs:
Quiet heart sounds
Pulsus paradoxus (an abnormally large fall in blood pressure during inspiration, notably when palpating the pulse)
Hypotension
Raised JVP
Fever (with pericarditis)
Pericardial rub (with pericarditis)

378
Q

How is pericardial effusion diagnosed?

A

Echocardiogram:
–> Diagnoses pericardial effusion
–> Assesses the size of the effusion and its effect on heart function
Fluid analysis:
–> Protein content
–> Bacterial culture
–> Viral PCR
–> Cytology and tumour markers for cancer

379
Q

How is pericardial effusion managed?

A

There are two components to treating a pericardial effusion:

Treatment of the underlying cause (e.g., infection)
Drainage of the effusion (where required)

Inflammatory causes (pericarditis) may be treated with:

Aspirin
NSAIDs
Colchicine
Steroids

There are two options for draining an effusion:

Needle pericardiocentesis (echocardiogram guided)
Surgical drainage

A pericardial window is a surgical procedure where a portion of the pericardium is removed, creating a “window” or fistula, that allows fluid to drain from the pericardial cavity into the pleural cavity or the peritoneal cavity.

Rarely, pericardiectomy (surgical removal of the pericardium) may be performed in recurrent cases.

380
Q

What is pericarditis?

A

Inflammation of the pericardium

381
Q

What is the pericardium, and what role does it play?

A

The pericardium (or pericardial sac) is the membrane surrounding the heart. It has two layers with a small amount of fluid (less than 50mls) in between, providing lubrication to allow the heart to beat without generating friction.

382
Q

What is the pericardial cavity, and why is it considered a “potential space”?

A

The pericardial cavity is the potential space between the two layers of the pericardium. The layers usually touch each other, which is why it is called a “potential” space.

383
Q

What are the potential underlying causes of pericarditis?

A

–> Idiopathic (no known cause)
–> Infection (e.g., tuberculosis, HIV, coxsackievirus, Epstein–Barr virus)
–> Autoimmune and inflammatory conditions (e.g., systemic lupus erythematosus, rheumatoid arthritis)
–> Injury to the pericardium (e.g., after –myocardial infarction, surgery, trauma)
–> Uraemia (due to renal impairment)
–> Cancer
–> Medications (e.g., methotrexate)

384
Q

What is pericardial effusion, and how does it affect the heart?

A

Pericardial effusion is the accumulation of fluid in the pericardial cavity, creating inward pressure on the heart, making it more difficult for the heart to expand during diastole (filling phase).

385
Q

What is pericardial tamponade, and why is it an emergency?

A

Pericardial tamponade is when the pericardial effusion becomes large enough to raise intra-pericardial pressure, compressing the heart and reducing filling during diastole. This decreases cardiac output during systole and is an emergency that requires immediate drainage.

386
Q

What are the major clinical features of acute pericarditis?

A

–> Retrosternal chest pain (85-90%):
Sharp and pleuritic
Improved by sitting up and leaning forward
May radiate to the trapezius ridge (specific for pericarditis)
–> Pericardial friction rub (≤33%):
Superficial, scratchy or squeaky quality
Best heard with the diaphragm at the left lower sternal border
Differentiated from pleural rub by asking the patient to hold their breath
Highly specific but low sensitivity
–> Other signs of infectious etiology:
Low-grade fever
Prodromal myalgia and malaise

387
Q

What are the recommended initial investigations for diagnosing acute pericarditis?

A

According to the ESC guidelines (2015), the recommended investigations for suspected acute pericarditis include:

Bedside tests:

ECG: Widespread concave ST-elevations saddle ST elevation and PR-segment depression (85% specific but not sensitive)
Bloods:

C-reactive protein, ESR, FBC: Elevated inflammatory markers support diagnosis (90% sensitivity)

Serum troponins: Elevated levels indicate myocardial involvement (myopericarditis) and poorer prognosis

Urea: Elevated in uraemic pericarditis
Imaging:

Echocardiography: Mild pericardial effusion seen in 60% of patients

Chest X-ray: Often normal, but can show cardiomegaly or associated lung pathology
Further Imaging:

CT and MRI: Consider for unclear diagnoses; MRI to confirm myocardial involvement
Pericardiocentesis: Only indicated for suspected bacterial or neoplastic causes or therapeutic drainage of a large effusion

Other investigations (if needed):

Blood cultures: If fever >38ºC or signs of sepsis
HIV serology
Interferon-gamma release assay or tuberculin skin test

388
Q

What are the key differential diagnoses for chest pain in acute pericarditis, and how do they compare?

A

–> Myocarditis
Similarities: ‘Stabbing’ chest pain, dyspnoea, signs of heart failure.
Differences: Myocarditis alone does not show ST-elevation on ECG. If there are elevated cardiac enzymes with widespread ST-elevation, it’s diagnosed as myopericarditis.

–> Acute Coronary Syndromes (ACS)
Similarities: Sharp chest pain, dyspnoea, may have elevated troponin levels.
Differences: Pleuritic chest pain is typically different, exacerbated by inspiration and lying supine. A pericardial rub may be present. ECG is critical for diagnosis.

–> Pulmonary Embolism (PE)
Similarities: Sudden onset chest pain, which may be pleuritic; a pleural rub may occasionally be heard.
Differences: Risk factors for PE (recent travel, immobility, surgery) differ from those for pericarditis. ECG may show tachycardia with right heart strain, not widespread ST-elevation.

389
Q

What are the key points in the management of acute pericarditis?

A

Outpatient Management:
–> The majority of patients can be managed as outpatients.

–> Inpatient Management:
Patients with high-risk features (e.g., fever > 38°C or elevated troponin) should be managed as inpatients.

–> Treat Underlying Causes:
Address any identifiable underlying cause if present.

–> Viral Infection:
Most cases are secondary to viral infection; thus, no specific antiviral treatment is indicated.

–> Activity Restrictions:
Avoid strenuous physical activity until symptoms resolve and inflammatory markers normalize.

–> First-line Treatment:
Use a combination of NSAIDs and colchicine for patients with acute idiopathic or viral pericarditis.
Continue until symptom resolution and normalization of inflammatory markers (usually 1-2 weeks), followed by a tapering dose.

390
Q

What are the signs of tricuspid regurgitation?

A

Pan-systolic murmur
Prominent/giant V waves in the JVP
Pulsatile hepatomegaly
Left parasternal heave

391
Q

What are the common causes of tricuspid regurgitation?

A

Right ventricular infarction
Pulmonary hypertension (e.g., COPD)
Rheumatic heart disease
Infective endocarditis (especially in intravenous drug users)
Ebstein’s anomaly
Carcinoid syndrome

392
Q

What are the common systolic and diastolic murmurs, and how can you remember them?

A

Systolic murmurs:

Aortic Stenosis (AS)
Mitral Regurgitation (MR)
Mnemonic: ASMR

Diastolic murmurs:
Aortic Regurgitation (AR)
Mitral Stenosis (MS)
Mnemonic: ARMS

393
Q

What are the aetiological groups of shock based on pathophysiology?

A

The pathophysiology of shock is divided into the following groups:

Septic (due to infection and systemic inflammation)
Haemorrhagic (due to blood loss)
Neurogenic (due to spinal cord or nerve injury)
Cardiogenic (due to heart failure)
Anaphylactic (due to severe allergic reaction)

394
Q

How is sepsis defined according to SIRS criteria?

A

Sepsis is an infection that triggers Systemic Inflammatory Response Syndrome (SIRS), characterized by:

Body temperature < 36°C or > 38°C
HR > 90 beats/min
Respiratory rate > 20/min
WBC > 12,000/mm³ or < 4,000/mm³
Patients with infection + 2 or more SIRS criteria are diagnosed with sepsis.

395
Q

What is severe sepsis and septic shock?

A

Severe sepsis: Sepsis with organ failure.
Septic shock: Sepsis with refractory hypotension.

396
Q

What is the pathophysiology of septic shock?

A

Marked immune activation with excessive cytokine release.
Endothelial cell damage and neutrophil adhesion.
Hallmarks: Excessive inflammation, coagulation, and fibrinolytic suppression.

397
Q

What are the key management strategies for septic shock according to the Surviving Sepsis Campaign (2012)?

A

Antibiotics: Prompt administration, broad-spectrum to cover likely pathogens.
Haemodynamic stabilisation: Aggressive fluid resuscitation; aim for CVP 8-12 cm H2O, MAP > 65 mmHg.
Modulate septic response: Tight glycaemic control; avoid routine steroid use.

398
Q

What are the 4 major classes of haemorrhagic shock based on blood loss?

A

Class I: < 750 mL (< 15% blood volume loss)
Class II: 750-1500 mL (15-30% loss)
Class III: 1500-2000 mL (30-40% loss)
Class IV: > 2000 mL (> 40% loss)

399
Q

What physiological changes are associated with Class I haemorrhagic shock?

A

Blood loss: < 750 mL (< 15%)
Pulse rate: < 100 bpm
Blood pressure: Normal
Respiratory rate: 14-20
Urine output: > 30 mL/hr
Symptoms: Normal

400
Q

What physiological changes are associated with Class II haemorrhagic shock?

A

Blood loss: 750-1500 mL (15-30%)
Pulse rate: > 100 bpm
Blood pressure: Normal
Respiratory rate: 20-30
Urine output: 20-30 mL/hr
Symptoms: Anxious

401
Q

What physiological changes are associated with Class III haemorrhagic shock?

A

Blood loss: 1500-2000 mL (30-40%)
Pulse rate: > 120 bpm
Blood pressure: Decreased
Respiratory rate: 30-40
Urine output: 5-15 mL/hr
Symptoms: Confused

402
Q

What physiological changes are associated with Class IV haemorrhagic shock?

A

Blood loss: > 2000 mL (> 40%)
Pulse rate: > 140 bpm
Blood pressure: Decreased
Respiratory rate: > 35
Urine output: < 5 mL/hr
Symptoms: Lethargic

403
Q

What are other causes of shock in trauma patients besides haemorrhage?

A

Tension pneumothorax
Spinal cord injury
Myocardial contusion
Cardiac tamponade

404
Q

What are the transfusion goals in haemorrhagic shock?

A

Maintain Hb of 7-8 g/dL in patients without risk factors for tissue hypoxia.
Maintain Hb of 10 g/dL in patients with risk factors for tissue hypoxia.

405
Q

What is neurogenic shock, and what causes it?

A

Neurogenic shock occurs most often after a spinal cord transection, usually at a high level, resulting in an interruption of the autonomic nervous system.

406
Q

What is the result of decreased sympathetic tone or increased parasympathetic tone in neurogenic shock?

A

There is decreased peripheral vascular resistance due to marked vasodilation, leading to reduced preload and cardiac output.

407
Q

How does neurogenic shock affect cardiac output and tissue perfusion?

A

Decreased preload leads to reduced cardiac output (Starling’s law), resulting in decreased peripheral tissue perfusion and shock.

408
Q

What is the contrast between neurogenic shock and other types of shock regarding vascular tone?

A

In neurogenic shock, peripheral vasoconstrictors are used to return vascular tone to normal, unlike many other types of shock.

409
Q

What is the main cause of cardiogenic shock in medical patients?

A

In medical patients, the main cause of cardiogenic shock is ischaemic heart disease.

410
Q

What are common causes of cardiogenic shock in trauma patients?

A

In trauma patients, direct myocardial trauma or contusion is more likely to cause cardiogenic shock.

411
Q

What imaging technique is used to assess myocardial injury in cardiogenic shock?

A

Transthoracic echocardiography should be used to assess for pericardial fluid or direct myocardial injury.

412
Q

How useful are troponin levels in trauma patients with cardiogenic shock?

A

Troponin levels may be measured, but they are less useful in delineating the extent of myocardial trauma than in myocardial infarction.

413
Q

Which part of the heart is most likely to be injured in blunt trauma associated with cardiogenic shock?

A

The right side of the heart is the most likely site of injury, including chamber or valve rupture.

414
Q

What is the management for patients with cardiogenic shock and right-sided heart injury?

A

Patients with cardiogenic shock and right-sided heart injury require surgery to repair defects, often needing cardiopulmonary bypass and potentially an intra-aortic balloon pump as a bridge to surgery.

415
Q

How is anaphylaxis defined?

A

Anaphylaxis is defined as a severe, life-threatening, generalised, or systemic hypersensitivity reaction.

416
Q

What is the most important drug in the treatment of anaphylaxis?

A

Adrenaline is the most important drug in the treatment of anaphylaxis and should be administered as soon as possible.

417
Q

How often can adrenaline be repeated in anaphylaxis?

A

Adrenaline can be repeated every 5 minutes if necessary during anaphylaxis.

418
Q

Where is the best site for intramuscular (IM) injection of adrenaline in anaphylaxis?

A

The best site for IM injection is the anterolateral aspect of the middle third of the thigh.

419
Q

What are some common causes of anaphylaxis?

A

Common causes of anaphylaxis include:

Food (e.g., nuts, especially common in children)
Drugs
Venom (e.g., wasp stings)

420
Q

What is the primary cause of angina?

A

Angina is primarily caused by atherosclerosis affecting the coronary arteries, which narrows the lumen and reduces blood flow to the myocardium (heart muscle).

421
Q

What triggers the symptoms of angina?

A

The symptoms of angina are triggered during times of high demand, such as exercise, when there is an insufficient supply of blood to meet the demand.

422
Q

How is stable angina defined?

A

Stable angina is defined as symptoms that occur only with exertion and are always relieved by rest or glyceryl trinitrate (GTN).

423
Q

What are the typical symptoms of angina?

A

The typical symptoms of angina include constricting chest pain, which may radiate to the jaw or arms.

424
Q

What baseline investigations should all patients with angina undergo?

A

All patients with angina should have the following baseline investigations:

Physical examination (heart sounds, signs of heart failure, blood pressure, and BMI)
ECG (a normal ECG does not exclude stable angina)
Full blood count (FBC) (to check for anaemia)
Urea and electrolytes (U&Es) (required before starting an ACE inhibitor and other medications)
Liver function tests (LFTs) (required before starting statins)
Lipid profile
Thyroid function tests (to check for hypothyroidism or hyperthyroidism)
HbA1C and fasting glucose (to check for diabetes)

425
Q

What is cardiac stress testing, and how is it performed?

A

Exercise testing (e.g., walking on a treadmill)
Pharmacological testing (e.g., administering dobutamine to stress the heart)
Assessment methods during stress testing include:
ECG
Echocardiogram
MRI
Myocardial perfusion scan (nuclear medicine scan)

426
Q

What is CT coronary angiography, and what does it assess?

A

CT coronary angiography involves injecting contrast and taking CT images timed with heart contractions to provide a detailed view of the coronary arteries, highlighting the specific locations of any narrowing.

427
Q

What is invasive coronary angiography, and how is it performed?

A

Invasive coronary angiography is performed in a catheter laboratory (cath lab). It involves:

Inserting a catheter into the patient’s brachial or femoral artery.
Directing it through the arterial system to the aorta and coronary arteries under x-ray guidance.
Injecting contrast to visualise the coronary arteries and identify any areas of stenosis using x-ray images.
This procedure is considered the gold standard for determining coronary artery disease.

428
Q

What are the five principles of management for stable angina, summarized by the “RAMPS” mnemonic?

A

The five principles of management for stable angina (RAMPS) are:

R – Refer to cardiology
A – Advise about the diagnosis, management, and when to call an ambulance
M – Medical treatment
P – Procedural or surgical interventions
S – Secondary prevention

429
Q

Where are referrals for stable angina usually sent?

A

Referrals are usually sent to the Rapid Access Chest Pain Clinic (RACPC).

430
Q

What are the three aims of medical management for stable angina?

A

The three aims of medical management for stable angina are:

Immediate symptomatic relief during episodes of angina
Long-term symptomatic relief
Secondary prevention of cardiovascular disease

431
Q

What is the first-line treatment for immediate symptomatic relief of angina?

A

Immediate symptomatic relief is achieved with sublingual glyceryl trinitrate (GTN) in the form of a spray or tablets.

432
Q

How should patients use sublingual GTN during an angina episode?

A

Take GTN when symptoms start.
Take a second dose after 5 minutes if symptoms remain.
Take a third dose after a further 5 minutes if symptoms persist.
Call an ambulance after a further 5 minutes if symptoms still remain.

433
Q

What are key side effects of glyceryl trinitrate (GTN)?

A

Key side effects of GTN are headaches and dizziness, caused by vasodilation.

434
Q

What are the first-line options for long-term symptomatic relief in stable angina?

A

First-line options for long-term symptomatic relief include:

Beta blockers (e.g., bisoprolol)
Calcium-channel blockers (e.g., diltiazem or verapamil, both avoided in heart failure with reduced ejection fraction)

435
Q

What are some specialist options for long-term symptomatic relief in stable angina?

A

Specialist options for long-term symptomatic relief include:

Long-acting nitrates (e.g., isosorbide mononitrate)
Ivabradine
Nicorandil
Ranolazine

436
Q

What medications are recommended for secondary prevention of cardiovascular disease in stable angina, remembered by the “four As” mnemonic?

A

The medications for secondary prevention are:

A – Aspirin 75mg once daily
A – Atorvastatin 80mg once daily
A – ACE inhibitor (if diabetes, hypertension, CKD, or heart failure are present)
A – Already on a beta blocker for symptomatic relief

437
Q

What is the definition of syncope?

A

Syncope is defined as a transient loss of consciousness due to global cerebral hypoperfusion, characterized by:

Rapid onset
Short duration
Spontaneous complete recovery
(Note: This definition excludes other causes of collapse, such as epilepsy.)

438
Q

What classification of syncope was suggested by the European Society of Cardiology in 2009?

A

–> Reflex syncope (neurally mediated)
Vasovagal: triggered by emotion, pain, or stress (often called ‘fainting’)
Situational: triggered by cough, micturition, or gastrointestinal events
Carotid sinus syncope
–> Orthostatic syncope
Primary autonomic failure: e.g., Parkinson’s disease, Lewy body dementia
Secondary autonomic failure: e.g., diabetic neuropathy, amyloidosis, uraemia
Drug-induced: e.g., diuretics, alcohol, vasodilators
Volume depletion: e.g., haemorrhage, diarrhoea
–> Cardiac syncope
Arrhythmias: bradycardias (sinus node dysfunction, AV conduction disorders) or tachycardias (supraventricular, ventricular)
Structural: e.g., valvular disease, myocardial infarction, hypertrophic obstructive cardiomyopathy
Others: e.g., pulmonary embolism

439
Q

What is the most common cause of syncope across all age groups?

A

Reflex syncope is the most common cause in all age groups, although orthostatic and cardiac causes become progressively more common in older patients.

440
Q

What are the key components of evaluating a patient with syncope?

A

Cardiovascular examination
Postural blood pressure readings:
A symptomatic fall in systolic BP > 20 mmHg or diastolic BP > 10 mmHg, or a decrease in systolic BP < 90 mmHg is considered diagnostic.
ECG for all patients
Other tests depend on clinical features
Patients with typical features, no postural drop, and a normal ECG do not require further investigations.

441
Q

What was the significant change in the NICE guidelines on lipid modification in 2014 regarding statin recommendations?

A

The guidelines recommended statins for a significant proportion of the population over the age of 60 years, particularly those with a 10-year cardiovascular disease (CVD) risk of 10% or greater, using the QRISK2 assessment tool.

442
Q

What is the QRISK2 CVD risk assessment tool used for, and in which patient populations should it be avoided?

A

The QRISK2 tool is used to assess the 10-year risk of CVD in patients aged ≤ 84 years. It should not be used in:

Type 1 diabetics
Patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min and/or albuminuria
Patients with a history of familial hyperlipidaemia

443
Q

What groups may have underestimated CVD risk when using QRISK2 according to NICE?

A

QRISK2 may underestimate CVD risk in:

People treated for HIV
People with serious mental health problems
Those taking medications causing dyslipidaemia (e.g., antipsychotics, corticosteroids)
People with autoimmune/systemic inflammatory disorders (e.g., systemic lupus erythematosus)

444
Q

What lipid measurements are recommended before starting a statin, and do the samples need to be fasting?

A

Before starting a statin, both total cholesterol and HDL levels should be checked, along with a full lipid profile (including triglycerides). The samples do not need to be fasting.

445
Q

When should familial hypercholesterolaemia be considered according to NICE guidelines?

A

Familial hypercholesterolaemia should be considered if:

Total cholesterol level > 7.5 mmol/L, and/or
There is a personal or family history of premature coronary heart disease (an event before age 60 in the index person or first-degree relative)

446
Q

What is the first-line statin recommended by NICE for primary prevention in eligible patients?

A

What is the first-line statin recommended by NICE for primary prevention in eligible patients?

447
Q

What are the specific recommendations for statin treatment in type 1 diabetes patients?

A

Statin treatment should be considered for primary prevention of CVD in all adults with type 1 diabetes who are:

Older than 40 years
Have had diabetes for more than 10 years
Have established nephropathy
Have other CVD risk factors
Atorvastatin 20 mg should be offered.

448
Q

What is the recommendation for statin use in patients with chronic kidney disease (CKD)?

A

Atorvastatin 20 mg should be offered to patients with CKD. The dose may be increased if a > 40% reduction in non-HDL cholesterol is not achieved and the eGFR > 30 ml/min. If eGFR < 30 ml/min, consult a renal specialist before increasing the dose.

449
Q

What is the recommended first-line statin dosage for secondary prevention in patients with CVD?

A

Atorvastatin 80 mg should be offered as the first-line statin for secondary prevention in patients with CVD.

450
Q

What is the follow-up procedure for patients started on statins according to NICE?

A

Patients should be followed up at 3 months with a full lipid profile. If non-HDL cholesterol has not decreased by at least 40%, concordance and lifestyle changes should be discussed. Consider increasing the atorvastatin dose up to 80 mg if necessary.

451
Q

What are the key lifestyle modifications recommended by NICE for patients at risk of CVD?

A

Diet:

Total fat intake ≤ 30% of total energy intake
Saturated fats ≤ 7% of total energy intake
Dietary cholesterol < 300 mg/day
Increase fruits, vegetables, and fish intake (including oily fish)
Choose wholegrain varieties and unsalted nuts, seeds, and legumes
Physical Activity:

Aim for 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity weekly
Engage in muscle-strengthening activities on 2 or more days a week
Weight Management:

Manage overweight patients as per relevant NICE guidance
Alcohol Intake:

Limit to a maximum of 14 units per week
Smoking Cessation:

Encourage smokers to quit.

452
Q

What are palmar xanthomas, and in which conditions may they be observed?

A

Palmar xanthomas are characteristic lesions associated with hyperlipidaemia. They are often seen in remnant hyperlipidaemia and may less commonly be present in familial hypercholesterolaemia.

453
Q

What are eruptive xanthomas, and what causes their appearance?

A

Eruptive xanthomas are due to high triglyceride levels and present as multiple red/yellow vesicles on extensor surfaces (e.g., elbows, knees). They are commonly associated with:

Familial hypertriglyceridaemia
Lipoprotein lipase deficiency

454
Q

What types of xanthomas are associated with familial hypercholesterolaemia and remnant hyperlipidaemia?

A

Tendon xanthoma, tuberous xanthoma, and xanthelasma are associated with familial hypercholesterolaemia and remnant hyperlipidaemia.

455
Q

What is xanthelasma, and where is it commonly found?

A

Xanthelasma are yellowish papules and plaques caused by localized accumulation of lipid deposits, commonly seen on the eyelid. They can also be found in patients without lipid abnormalities.

456
Q

What are the management options for xanthelasma?

A

Management options for xanthelasma include:

Surgical excision
Topical trichloroacetic acid
Laser therapy
Electrodesiccation

457
Q
A